7Baggers

Bristol-Myers Squibb Company
(NYSE:BMY) 

BMY stock logo

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. Its products include Revlimid, an oral immunomodulatory drug for the tr...

Founded: 1887
Full Time Employees: 30,000
Sector: Healthcare
Industry: Drug Manufacturers-General

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 
                                                                     
      net product sales
    11,168,000,000 12,111,000,000 11,850,000,000 11,909,000,000 10,886,000,000 11,811,000,000 11,483,000,000 11,925,000,000 11,559,000,000 11,168,000,000 10,645,000,000 10,917,000,000 11,048,000,000 11,065,000,000 10,813,000,000 11,485,000,000 11,308,000,000 11,609,000,000 11,243,000,000 11,405,000,000 10,798,000,000 10,766,000,000 10,197,000,000 9,817,000,000 10,541,000,000 7,662,000,000 5,768,000,000 6,031,000,000 5,713,000,000 5,715,000,000 5,433,000,000 5,461,000,000 4,972,000,000 5,046,000,000 4,862,000,000 4,770,000,000 4,580,000,000 4,814,000,000 4,492,000,000 4,432,000,000 3,964,000,000 3,862,000,000 3,552,000,000 3,572,000,000 3,059,000,000 3,240,000,000 2,843,000,000 2,770,000,000 2,807,000,000                 
      alliance and other revenues
    321,000,000 391,000,000 372,000,000 360,000,000 315,000,000 531,000,000 409,000,000 276,000,000 306,000,000 309,000,000 321,000,000 309,000,000 289,000,000 341,000,000 405,000,000 402,000,000 340,000,000 376,000,000 381,000,000 298,000,000 275,000,000 302,000,000 343,000,000 312,000,000 240,000,000 283,000,000 239,000,000 242,000,000 207,000,000 258,000,000 258,000,000 243,000,000 221,000,000 403,000,000 392,000,000 374,000,000 349,000,000 429,000,000 430,000,000 439,000,000 427,000,000 425,000,000 517,000,000 591,000,000 982,000,000 1,018,000,000 1,078,000,000 1,119,000,000 1,004,000,000                 
      total revenues
    11,489,000,000 12,502,000,000 12,222,000,000 12,269,000,000 11,201,000,000 12,342,000,000 11,892,000,000 12,201,000,000 11,865,000,000 11,477,000,000 10,966,000,000 11,226,000,000 11,337,000,000 11,406,000,000 11,218,000,000 11,887,000,000 11,648,000,000 11,985,000,000 11,624,000,000 11,703,000,000 11,073,000,000 11,068,000,000 10,540,000,000 10,129,000,000 10,781,000,000 7,945,000,000 6,007,000,000 6,273,000,000 5,920,000,000 5,973,000,000 5,691,000,000 5,704,000,000 5,193,000,000 5,449,000,000 5,254,000,000 5,144,000,000 4,929,000,000 5,243,000,000 4,922,000,000 4,871,000,000 4,391,000,000 4,287,000,000 4,069,000,000 4,163,000,000 4,041,000,000 4,258,000,000 3,921,000,000 3,889,000,000 3,811,000,000                 
      yoy
    2.57% 1.30% 2.77% 0.56% -5.60% 7.54% 8.44% 8.69% 4.66% 0.62% -2.25% -5.56% -2.67% -4.83% -3.49% 1.57% 5.19% 8.29% 10.28% 15.54% 2.71% 39.31% 75.46% 61.47% 82.11% 33.02% 5.55% 9.98% 14.00% 9.62% 8.32% 10.89% 5.36% 3.93% 6.75% 5.60% 12.25% 22.30% 20.96% 17.01% 8.66% 0.68% 3.77% 7.05% 6.04%                     
      qoq
    -8.10% 2.29% -0.38% 9.53% -9.24% 3.78% -2.53% 2.83% 3.38% 4.66% -2.32% -0.98% -0.60% 1.68% -5.63% 2.05% -2.81% 3.11% -0.68% 5.69% 0.05% 5.01% 4.06% -6.05% 35.70% 32.26% -4.24% 5.96% -0.89% 4.96% -0.23% 9.84% -4.70% 3.71% 2.14% 4.36% -5.99% 6.52% 1.05% 10.93% 2.43% 5.36% -2.26% 3.02% -5.10% 8.59% 0.82% 2.05%                  
      cost of products sold
    3,421,000,000 4,097,000,000 3,435,000,000 3,372,000,000 3,033,000,000 4,812,000,000 2,957,000,000 3,267,000,000 2,932,000,000 2,745,000,000 2,506,000,000 2,876,000,000 2,566,000,000 2,593,000,000 2,353,000,000 2,720,000,000 2,471,000,000 2,356,000,000 2,291,000,000 2,452,000,000 2,841,000,000 2,910,000,000 2,502,000,000 2,699,000,000 3,662,000,000 2,432,000,000 1,810,000,000 1,992,000,000 1,844,000,000 1,690,000,000 1,648,000,000 1,625,000,000 1,584,000,000 1,673,000,000 1,572,000,000 1,562,000,000 1,259,000,000 1,383,000,000 1,305,000,000 1,206,000,000 1,052,000,000 952,000,000 1,097,000,000 1,013,000,000 847,000,000 966,000,000 1,007,000,000 991,000,000 968,000,000 1,273,000,000 1,175,000,000 1,108,000,000 1,063,000,000 1,075,000,000 987,000,000 1,245,000,000 1,303,000,000 1,367,000,000 1,407,000,000 1,481,000,000 1,343,000,000 1,414,000,000 1,280,000,000 1,277,000,000 1,306,000,000 
      selling, general and administrative
    1,617,000,000 2,181,000,000 1,789,000,000 1,713,000,000 1,584,000,000                                                             
      research and development
    2,649,000,000 2,586,000,000 2,528,000,000 2,580,000,000 2,257,000,000 3,191,000,000 2,374,000,000 2,899,000,000 2,695,000,000 2,478,000,000 2,242,000,000 2,258,000,000 2,321,000,000 2,510,000,000 2,418,000,000 2,321,000,000 2,260,000,000 2,607,000,000 3,251,000,000 3,271,000,000 2,225,000,000 3,750,000,000 2,499,000,000 2,522,000,000 2,372,000,000 2,087,000,000 1,382,000,000 1,328,000,000 1,351,000,000 1,380,000,000 1,280,000,000 2,435,000,000 1,250,000,000 1,921,000,000 1,543,000,000 1,659,000,000 1,288,000,000 1,400,000,000 1,138,000,000 1,266,000,000 1,136,000,000 1,916,000,000 1,132,000,000 1,856,000,000 1,016,000,000 1,189,000,000 983,000,000 1,416,000,000 946,000,000 957,000,000 893,000,000 951,000,000 930,000,000 1,082,000,000 951,000,000 962,000,000 909,000,000 1,008,000,000 973,000,000 923,000,000 935,000,000 1,010,000,000 824,000,000 822,000,000 910,000,000 
      acquired iprd
    94,000,000 1,393,000,000 633,000,000 1,508,000,000 188,000,000 30,000,000 262,000,000 132,000,000 12,949,000,000 600,000,000 80,000,000 158,000,000 75,000,000 52,000,000 30,000,000 400,000,000 333,000,000                                                 
      amortization of acquired intangible assets
    437,000,000 826,000,000 831,000,000 830,000,000 830,000,000 1,693,000,000 2,406,000,000 2,416,000,000 2,357,000,000 2,278,000,000 2,256,000,000 2,257,000,000 2,256,000,000 2,343,000,000 2,418,000,000 2,417,000,000 2,417,000,000 2,417,000,000 2,546,000,000 2,547,000,000 2,513,000,000 2,526,000,000 2,491,000,000 2,389,000,000 2,282,000,000                                         
      other expense
    32,000,000 -51,000,000 -108,000,000 494,000,000 339,000,000 305,000,000 234,000,000 273,000,000 81,000,000 -371,000,000 -258,000,000 -116,000,000 -413,000,000 -217,000,000 -140,000,000 284,000,000 649,000,000 393,000,000 -409,000,000 -2,000,000 -702,000,000 -1,826,000,000 -915,000,000 -736,000,000 1,163,000,000         -344,250,000 -191,000,000 -539,000,000 -647,000,000 -87,000,000 -224,000,000 -454,000,000 -520,000,000 328,000,000 -323,000,000 107,000,000 -299,000,000 799,000,000 -277,000,000 -104,000,000 -208,000,000   199,000,000 -19,000,000 -11,250,000 -50,000,000 -18,000,000 23,000,000 26,000,000 -26,000,000 -31,000,000 -138,000,000 42,000,000 -10,000,000 -19,000,000 113,000,000 
      total expenses
    8,250,000,000 11,032,000,000 9,108,000,000 10,496,000,000 8,230,000,000 12,167,000,000 10,216,000,000 10,915,000,000 23,381,000,000 9,803,000,000 8,829,000,000 9,367,000,000 8,567,000,000 9,547,000,000 9,009,000,000 9,929,000,000 9,961,000,000 10,127,000,000 9,467,000,000 10,150,000,000 8,543,000,000 21,519,000,000 8,283,000,000 8,502,000,000 11,085,000,000 8,074,000,000 4,658,000,000 4,497,000,000 3,941,000,000 4,468,000,000 3,524,000,000 5,187,000,000 3,414,000,000 4,751,000,000 4,071,000,000 3,849,000,000 2,974,000,000 4,157,000,000 3,363,000,000 3,256,000,000 2,736,000,000 4,697,000,000 3,082,000,000 4,111,000,000 2,593,000,000 4,318,000,000 2,913,000,000 3,441,000,000 2,826,000,000 3,572,000,000 3,247,000,000 3,518,000,000 3,157,000,000 3,678,000,000 4,995,000,000 3,384,000,000 3,224,000,000 3,860,000,000 3,515,000,000 3,644,000,000 3,244,000,000 3,698,000,000 3,184,000,000 3,176,000,000 3,355,000,000 
      earnings before income taxes
    3,240,000,000 1,470,000,000 3,114,000,000 1,773,000,000 2,971,000,000 175,000,000 1,676,000,000 1,286,000,000 -11,516,000,000 1,674,000,000 2,137,000,000 1,859,000,000 2,770,000,000 1,859,000,000 2,209,000,000 1,958,000,000 1,687,000,000 1,858,000,000 2,157,000,000 1,553,000,000 2,530,000,000 -10,451,000,000 2,257,000,000 1,627,000,000 -304,000,000 -129,000,000 1,349,000,000 1,776,000,000 1,979,000,000 1,505,000,000 2,167,000,000 517,000,000 1,779,000,000 698,000,000 1,183,000,000 1,295,000,000 1,955,000,000 1,086,000,000 1,559,000,000 1,615,000,000 1,655,000,000 -410,000,000 987,000,000 52,000,000 1,448,000,000 -60,000,000 1,008,000,000 448,000,000 985,000,000 869,000,000 818,000,000 530,000,000 674,000,000 513,000,000 -1,259,000,000 1,059,000,000 2,027,000,000 1,346,750,000 1,830,000,000 1,790,000,000 1,767,000,000     
      income tax provision
    561,000,000 384,000,000 919,000,000 460,000,000 509,000,000 99,000,000 461,000,000 -398,000,000 392,000,000 122,000,000 203,000,000 -218,000,000                                                      
      net earnings
    2,678,000,000 1,085,000,000 2,195,000,000 1,313,000,000 2,462,000,000 76,000,000 1,215,000,000 1,684,000,000 -11,908,000,000 1,762,000,000 1,934,000,000 2,077,000,000 2,267,000,000 2,025,000,000 1,608,000,000 1,429,000,000 1,283,000,000 2,372,000,000 1,552,000,000 1,061,000,000 2,029,000,000 -10,027,000,000 1,878,000,000 -80,000,000 -766,000,000 -1,060,000,000 1,366,000,000 1,439,000,000 1,715,000,000 1,158,000,000 1,912,000,000 382,000,000 1,495,000,000 -2,329,000,000 856,000,000 922,000,000 1,526,000,000 898,000,000 1,215,000,000 1,188,000,000 1,206,000,000 -188,000,000 730,000,000 -110,000,000 1,199,000,000 27,000,000 732,000,000 334,000,000 936,000,000 735,000,000 692,000,000 530,000,000 623,000,000 924,000,000 -713,000,000 808,000,000 1,482,000,000 1,231,000,000 1,355,000,000 1,307,000,000 1,367,000,000 842,000,000 1,302,000,000 1,268,000,000 1,101,000,000 
      yoy
    8.77% 1327.63% 80.66% -22.03% -120.68% -95.69% -37.18% -18.92% -625.28% -12.99% 20.27% 45.35% 76.70% -14.63% 3.61% 34.68% -36.77% -123.66% -17.36% -1426.25% -364.88% 845.94% 37.48% -105.56% -144.66% -191.54% -28.56% 276.70% 14.72% -149.72% 123.36% -58.57% -2.03% -359.35% -29.55% -22.39% 26.53% -577.66% 66.44% -1180.00% 0.58% -796.30% -0.27% -132.93% 28.10% -96.33% 5.78% -36.98% 50.24% -20.45% -197.05% -34.41% -57.96% -24.94% -152.62% -38.18% 8.41% 46.20% 4.07% 3.08% 24.16%     
      qoq
    146.82% -50.57% 67.17% -46.67% 3139.47% -93.74% -27.85% -114.14% -775.82% -8.89% -6.88% -8.38% 11.95% 25.93% 12.53% 11.38% -45.91% 52.84% 46.28% -47.71% -120.24% -633.92% -2447.50% -89.56% -27.74% -177.60% -5.07% -16.09% 48.10% -39.44% 400.52% -74.45% -164.19% -372.08% -7.16% -39.58% 69.93% -26.09% 2.27% -1.49% -741.49% -125.75% -763.64% -109.17% 4340.74% -96.31% 119.16% -64.32% 27.35% 6.21% 30.57% -14.93% -32.58% -229.59% -188.24% -45.48% 20.39% -9.15% 3.67% -4.39% 62.35% -35.33% 2.68% 15.17%  
      net income margin %
    23.31% 8.68% 17.96% 10.70% 21.98% 0.62% 10.22% 13.80% -100.36% 15.35% 17.64% 18.50% 20.00% 17.75% 14.33% 12.02% 11.01% 19.79% 13.35% 9.07% 18.32% -90.59% 17.82% -0.79% -7.11% -13.34% 22.74% 22.94% 28.97% 19.39% 33.60% 6.70% 28.79% -42.74% 16.29% 17.92% 30.96% 17.13% 24.69% 24.39% 27.47% -4.39% 17.94% -2.64% 29.67% 0.63% 18.67% 8.59% 24.56% Infinity% Infinity% Infinity% Infinity% Infinity% -Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% 
      noncontrolling interest
    1,000,000 -1,000,000 -6,000,000 2,000,000 6,000,000 4,000,000 4,000,000 4,000,000 3,000,000  6,000,000 4,000,000 5,000,000 3,000,000 2,000,000 8,000,000 5,000,000  6,000,000 6,000,000 8,000,000  6,000,000 5,000,000 9,000,000 -4,000,000 13,000,000 7,000,000 5,000,000 -2,000,000 11,000,000 9,000,000 9,000,000                                 
      net earnings attributable to bms
    2,677,000,000 1,087,000,000 2,201,000,000 1,310,000,000 2,456,000,000 72,000,000 1,211,000,000 1,680,000,000 -11,911,000,000 1,762,000,000 1,928,000,000 2,073,000,000 2,262,000,000 2,022,000,000 1,606,000,000 1,421,000,000 1,278,000,000 2,372,000,000 1,546,000,000 1,055,000,000 2,021,000,000 -10,027,000,000 1,872,000,000 -85,000,000 -775,000,000 -1,056,000,000 1,353,000,000 1,432,000,000 1,710,000,000 1,160,000,000 1,901,000,000 373,000,000 1,486,000,000 -2,328,000,000 845,000,000 916,000,000 1,574,000,000 894,000,000 1,202,000,000 1,166,000,000 1,195,000,000 -197,000,000 706,000,000 -130,000,000 1,186,000,000 13,000,000 721,000,000 333,000,000 937,000,000 726,000,000 692,000,000 536,000,000 609,000,000 925,000,000 -711,000,000           
      earnings per common share:
                                                                     
      basic
    1,310,000 540,000 1,080,000 640,000 1,210,000 40,000 600,000 830,000 -5,890,000 870,000 940,000 990,000 1,080,000 960,000 750,000 670,000 600,000 1,070,000 700,000 470,000 900,000 -4,440,000 830,000 -40,000 -340,000 -730,000 830,000 880,000 1,050,000 710,000 1,160,000 230,000 910,000 -1,410,000 520,000 560,000 950,000 540,000 720,000 700,000 720,000 -120,000 420,000 -80,000 710,000 10,000 430,000 200,000 570,000 440,000 420,000 330,000 370,000 550,000 -430,000 380,000 650,000 510,000 570,000 530,000 580,000 280,000 550,000 540,000 430,000 
      diluted
    1,310,000 530,000 1,080,000 640,000 1,200,000 40,000 600,000 830,000 -5,890,000 870,000 930,000 990,000 1,070,000 950,000 750,000 660,000 590,000 1,070,000 690,000 470,000 890,000 -4,430,000 820,000 -40,000 -340,000 -740,000 830,000 870,000 1,040,000 710,000 1,160,000 230,000 910,000 -1,410,000 510,000 560,000 940,000 530,000 720,000 690,000 710,000 -120,000 420,000 -80,000 710,000 10,000 430,000 200,000 560,000 430,000 420,000 320,000 370,000 550,000 -430,000 380,000 640,000 500,000 560,000 520,000 570,000 280,000 550,000 530,000 430,000 
      marketing, selling and administrative
         2,136,000,000 1,983,000,000 1,928,000,000 2,367,000,000 2,073,000,000 2,003,000,000 1,934,000,000 1,762,000,000 2,266,000,000 1,930,000,000 1,787,000,000 1,831,000,000 2,354,000,000 1,788,000,000 1,882,000,000 1,666,000,000 2,721,000,000 1,706,000,000 1,628,000,000 1,606,000,000 1,734,000,000 1,055,000,000 1,076,000,000 1,006,000,000 1,336,000,000 1,104,000,000 1,131,000,000 980,000,000 1,299,000,000 1,147,000,000 1,167,000,000 1,074,000,000 1,461,000,000 1,144,000,000 1,238,000,000 1,068,000,000 1,996,000,000 983,000,000 968,000,000 894,000,000 1,151,000,000 1,029,000,000 951,000,000 957,000,000 1,068,000,000 980,000,000 1,042,000,000 994,000,000 1,143,000,000 1,071,000,000 1,004,000,000 1,002,000,000 1,216,000,000 1,019,000,000 1,040,000,000 928,000,000 1,000,000,000 892,000,000 894,000,000 900,000,000 
      provision for income taxes
                503,000,000 -166,000,000 601,000,000 529,000,000 404,000,000 -514,000,000 605,000,000 492,000,000 501,000,000 -424,000,000 379,000,000 1,707,000,000 462,000,000 931,000,000 -17,000,000 337,000,000 264,000,000 347,000,000 255,000,000 135,000,000 284,000,000 3,027,000,000 327,000,000 373,000,000 429,000,000 188,000,000 344,000,000 427,000,000 449,000,000 -222,000,000 257,000,000 162,000,000 249,000,000 -87,000,000 276,000,000 114,000,000 49,000,000    51,000,000 62,500,000 -546,000,000 251,000,000 545,000,000 363,000,000 475,000,000 483,000,000 400,000,000 571,000,000 312,000,000 324,000,000 351,000,000 
      other income
                             63,000,000 411,000,000 101,000,000 -260,000,000 62,000,000 -508,000,000 -4,000,000 -400,000,000                                 
      cash dividends declared per common share
                                 300,000 400,000 400,000 400,000 400,000 390,000 390,000 390,000 390,000 380,000 380,000 380,000 380,000 370,000 370,000 370,000 370,000 360,000 360,000 360,000 360,000 350,000 350,000 350,000             
      net earnings attributable to noncontrolling interest
                                     -7,750,000 11,000,000 6,000,000 -48,000,000 4,000,000 13,000,000 22,000,000 11,000,000 9,000,000 24,000,000 20,000,000 13,000,000 14,000,000 11,000,000 1,000,000 -1,000,000   -6,000,000 14,000,000 -1,000,000 -2,000,000 163,000,000 381,000,000 379,000,000 386,000,000 405,000,000 381,000,000 359,000,000 353,000,000 341,000,000 358,000,000 
      advertising and product promotion
                                             123,750,000 193,000,000 167,000,000 135,000,000 213,000,000 171,000,000 187,000,000 163,000,000 254,000,000 194,000,000 218,000,000 189,000,000 212,000,000 167,000,000 224,000,000 194,000,000 285,000,000 205,000,000 253,000,000 214,000,000 271,000,000 231,000,000 263,000,000 212,000,000 
      net sales
                                                     2,986,000,000 4,065,000,000 4,048,000,000 3,831,000,000 4,191,000,000 3,736,000,000 4,443,000,000 5,251,000,000 5,454,000,000 5,345,000,000 5,434,000,000 5,011,000,000 5,111,000,000 4,798,000,000 4,768,000,000 4,807,000,000 
      impairment charge for bms-986094 intangible asset
                                                          1,830,000,000           
      other (income)/expense
                                                     20,000,000 5,000,000               
      benefit from/(benefit from) income taxes
                                                     134,000,000 126,000,000               
      net earnings/(loss) attributable to noncontrolling interest
                                                     2,000,000                
      provision for restructuring
                                                         17,750,000 29,000,000 20,000,000 22,000,000 24,000,000 8,000,000 40,000,000 44,000,000 63,000,000 15,000,000 24,000,000 11,000,000 
      litigation expense/
                                                         -30,500,000 50,000,000  -172,000,000         
      equity in net income of affiliates
                                                         -37,500,000 -40,000,000 -53,000,000 -57,000,000 -66,000,000 -71,000,000 -62,000,000 -82,000,000 -61,000,000 -70,000,000 -85,000,000 -97,000,000 
      earnings per common share attributable to bms
                                                                     
      basic
    1,310,000 540,000 1,080,000 640,000 1,210,000 40,000 600,000 830,000 -5,890,000 870,000 940,000 990,000 1,080,000 960,000 750,000 670,000 600,000 1,070,000 700,000 470,000 900,000 -4,440,000 830,000 -40,000 -340,000 -730,000 830,000 880,000 1,050,000 710,000 1,160,000 230,000 910,000 -1,410,000 520,000 560,000 950,000 540,000 720,000 700,000 720,000 -120,000 420,000 -80,000 710,000 10,000 430,000 200,000 570,000 440,000 420,000 330,000 370,000 550,000 -430,000 380,000 650,000 510,000 570,000 530,000 580,000 280,000 550,000 540,000 430,000 
      diluted
    1,310,000 530,000 1,080,000 640,000 1,200,000 40,000 600,000 830,000 -5,890,000 870,000 930,000 990,000 1,070,000 950,000 750,000 660,000 590,000 1,070,000 690,000 470,000 890,000 -4,430,000 820,000 -40,000 -340,000 -740,000 830,000 870,000 1,040,000 710,000 1,160,000 230,000 910,000 -1,410,000 510,000 560,000 940,000 530,000 720,000 690,000 710,000 -120,000 420,000 -80,000 710,000 10,000 430,000 200,000 560,000 430,000 420,000 320,000 370,000 550,000 -430,000 380,000 640,000 500,000 560,000 520,000 570,000 280,000 550,000 530,000 430,000 
      dividends declared per common share
                                                         255,000 340,000 340,000 340,000 340,000 330,000 330,000 330,000 330,000 320,000 320,000 320,000 
      net earnings attributable to bristol-myers squibb company
                                                           645,000,000 1,101,000,000 852,000,000 969,000,000 902,000,000 986,000,000 483,000,000 949,000,000 927,000,000 743,000,000 
      litigation expense
                                                                 -41,000,000 22,000,000   
      earnings from continuing operations before income taxes
                                                                 1,413,000,000 1,614,000,000 1,592,000,000 1,452,000,000 
      net earnings from continuing operations
                                                                 842,000,000 1,302,000,000 1,268,000,000 1,101,000,000 
      discontinued operations:
                                                                     
      earnings, net of taxes
                                                                     
      gain on disposal, net of taxes
                                                                     
      net earnings from discontinued operations
                                                                     
      amounts attributable to bristol-myers squibb company:
                                                                     
      earnings per common share attributable to bristol-myers squibb company:
                                                                     
      net loss from discontinued operations
                                                                     
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 
                                                                       
        current assets:
                                                                       
        cash and cash equivalents
      9,574,000,000 10,209,000,000 15,726,000,000 12,599,000,000 10,875,000,000 10,346,000,000 7,890,000,000 6,293,000,000 9,330,000,000 11,464,000,000 7,514,000,000 8,372,000,000 8,995,000,000 9,123,000,000 7,734,000,000 10,750,000,000 12,369,000,000 13,979,000,000 13,540,000,000 11,024,000,000 10,982,000,000 14,546,000,000 19,435,000,000 19,934,000,000 15,817,000,000 12,346,000,000 30,489,000,000 28,404,000,000 7,335,000,000 6,911,000,000 5,408,000,000 4,999,000,000 5,342,000,000 5,421,000,000 4,644,000,000 3,470,000,000 3,910,000,000 4,237,000,000 3,432,000,000 2,934,000,000 2,644,000,000 2,385,000,000 3,975,000,000 4,199,000,000 6,294,000,000 5,571,000,000 4,851,000,000 4,282,000,000 5,225,000,000 3,586,000,000 1,771,000,000 1,821,000,000 1,355,000,000 1,656,000,000 1,503,000,000 2,801,000,000 2,307,000,000 5,776,000,000 4,471,000,000 3,665,000,000 3,405,000,000 5,033,000,000 7,581,000,000 5,918,000,000 5,135,000,000 
        marketable debt securities
      912,000,000 464,000,000 776,000,000 1,004,000,000 907,000,000 513,000,000 204,000,000 360,000,000 340,000,000 816,000,000 171,000,000 358,000,000 274,000,000 130,000,000 1,293,000,000 2,478,000,000 2,599,000,000 2,987,000,000 2,123,000,000 1,946,000,000 1,948,000,000 1,285,000,000 1,720,000,000 1,724,000,000 2,505,000,000 3,047,000,000                                        
        receivables
      9,368,000,000 11,414,000,000 11,422,000,000 11,415,000,000 10,801,000,000 10,747,000,000 11,026,000,000 11,423,000,000 10,447,000,000 10,921,000,000 10,304,000,000 10,112,000,000 10,054,000,000 9,886,000,000 9,613,000,000 9,054,000,000 8,511,000,000 9,369,000,000 9,245,000,000 9,017,000,000 8,660,000,000 8,501,000,000 8,062,000,000 7,855,000,000 8,290,000,000 7,685,000,000 5,510,000,000 5,667,000,000 5,704,000,000 5,965,000,000 5,871,000,000 5,559,000,000 5,683,000,000 6,300,000,000 5,922,000,000 5,782,000,000 5,494,000,000 5,543,000,000 5,597,000,000 5,622,000,000 4,957,000,000 4,299,000,000 3,908,000,000 3,672,000,000 3,458,000,000 3,390,000,000 3,321,000,000 3,315,000,000 3,316,000,000 3,360,000,000 3,673,000,000 3,406,000,000 3,308,000,000 3,083,000,000 2,889,000,000 2,825,000,000 3,613,000,000 3,743,000,000 3,687,000,000 4,059,000,000 3,587,000,000 3,480,000,000 3,285,000,000 3,172,000,000 3,459,000,000 
        inventories
      2,756,000,000 2,690,000,000 2,758,000,000 2,737,000,000 2,666,000,000 2,557,000,000 3,332,000,000 3,077,000,000 2,985,000,000 2,662,000,000 2,436,000,000 2,364,000,000 2,605,000,000 2,339,000,000 2,074,000,000 2,142,000,000 2,104,000,000 2,095,000,000 2,163,000,000 2,137,000,000 1,953,000,000 2,074,000,000 1,949,000,000 2,384,000,000 2,836,000,000 4,293,000,000 1,192,000,000 1,308,000,000 1,283,000,000 1,195,000,000 1,282,000,000 1,242,000,000 1,231,000,000 1,166,000,000 1,250,000,000 1,217,000,000 1,384,000,000 1,241,000,000 1,482,000,000 1,437,000,000 1,336,000,000 1,221,000,000 1,130,000,000 1,304,000,000 1,437,000,000 1,560,000,000 1,565,000,000 1,666,000,000 1,655,000,000 1,498,000,000 1,640,000,000 1,785,000,000 1,791,000,000 1,657,000,000 1,697,000,000 1,521,000,000 1,463,000,000 1,384,000,000 1,357,000,000 1,492,000,000 1,322,000,000 1,204,000,000 1,369,000,000 1,265,000,000 1,284,000,000 
        other current assets
      4,597,000,000 4,613,000,000 4,948,000,000 5,466,000,000 5,534,000,000 5,617,000,000 5,623,000,000 5,737,000,000 5,567,000,000 5,907,000,000 7,207,000,000 6,868,000,000 5,158,000,000 5,795,000,000 6,082,000,000 5,762,000,000 4,538,000,000 4,832,000,000 4,372,000,000 5,037,000,000 3,568,000,000 3,786,000,000 3,111,000,000 2,446,000,000 2,405,000,000 1,983,000,000                                        
        total current assets
      27,208,000,000 29,390,000,000 35,630,000,000 33,222,000,000 30,783,000,000 29,780,000,000 28,075,000,000 26,890,000,000 28,669,000,000 31,770,000,000 27,632,000,000 28,074,000,000 27,086,000,000 27,273,000,000 26,796,000,000 30,186,000,000 30,121,000,000 33,262,000,000 31,443,000,000 29,161,000,000 27,111,000,000 30,192,000,000 34,277,000,000 34,343,000,000 31,853,000,000 29,354,000,000 40,191,000,000 37,716,000,000 17,093,000,000 17,160,000,000 14,869,000,000 13,874,000,000 14,649,000,000 14,854,000,000 15,048,000,000 14,324,000,000 13,615,000,000 13,704,000,000 13,204,000,000 12,298,000,000 11,215,000,000 10,415,000,000 12,926,000,000 13,056,000,000 14,925,000,000 14,608,000,000 14,177,000,000 14,062,000,000 14,014,000,000 18,916,000,000 10,627,000,000 10,486,000,000 10,076,000,000 9,521,000,000 9,278,000,000 11,013,000,000 11,765,000,000 15,318,000,000 14,869,000,000 14,775,000,000 13,296,000,000 13,273,000,000 14,376,000,000 12,983,000,000 12,532,000,000 
        property, plant and equipment
      7,658,000,000 7,543,000,000 7,349,000,000 7,373,000,000 7,213,000,000 7,136,000,000 6,903,000,000 6,845,000,000 6,750,000,000 6,646,000,000 6,481,000,000 6,355,000,000 6,279,000,000 6,255,000,000 6,035,000,000 5,970,000,000 6,047,000,000 6,049,000,000 5,868,000,000 5,795,000,000 5,763,000,000 5,886,000,000 5,740,000,000 5,777,000,000 6,112,000,000 6,252,000,000 4,830,000,000 4,849,000,000 4,985,000,000 5,027,000,000 5,092,000,000 5,080,000,000 5,060,000,000 5,001,000,000 5,014,000,000 4,944,000,000 5,020,000,000 4,980,000,000 4,790,000,000 4,597,000,000 4,455,000,000 4,412,000,000 4,249,000,000 4,363,000,000 4,323,000,000 4,417,000,000 4,387,000,000 4,438,000,000 4,485,000,000 4,579,000,000 5,236,000,000 5,228,000,000 5,259,000,000 5,333,000,000 5,297,000,000 4,478,000,000 4,512,000,000 4,521,000,000 4,492,000,000 4,554,000,000 4,604,000,000 4,664,000,000 4,723,000,000 4,745,000,000 4,822,000,000 
        goodwill
      21,740,000,000 21,754,000,000 21,745,000,000 21,776,000,000 21,737,000,000 21,719,000,000 21,751,000,000 21,732,000,000 21,738,000,000 21,169,000,000 21,147,000,000 21,163,000,000 21,162,000,000 21,149,000,000 21,112,000,000 20,446,000,000 20,500,000,000 20,502,000,000 20,519,000,000 20,529,000,000 20,524,000,000 20,547,000,000 20,517,000,000 20,578,000,000 22,452,000,000 22,488,000,000 6,513,000,000 6,533,000,000 6,536,000,000 6,538,000,000 6,686,000,000 6,683,000,000 6,863,000,000 6,863,000,000 6,865,000,000 6,861,000,000 6,875,000,000 6,875,000,000 6,875,000,000 6,875,000,000 6,875,000,000 6,881,000,000 6,952,000,000 6,976,000,000 7,027,000,000 7,027,000,000 7,046,000,000 7,046,000,000 7,046,000,000 7,096,000,000 7,646,000,000 7,646,000,000 7,646,000,000 7,635,000,000 7,498,000,000 6,799,000,000 6,799,000,000 5,586,000,000 5,564,000,000 5,233,000,000 5,233,000,000 5,233,000,000 5,218,000,000 5,218,000,000 5,218,000,000 
        other intangible assets
      18,244,000,000 19,103,000,000 20,465,000,000 21,378,000,000 22,486,000,000 23,307,000,000 26,964,000,000 29,428,000,000 32,760,000,000 27,072,000,000 28,950,000,000 31,303,000,000 33,569,000,000 35,859,000,000 38,179,000,000 37,690,000,000 40,103,000,000 42,527,000,000 44,930,000,000 48,065,000,000 50,819,000,000 53,243,000,000 56,698,000,000 59,171,000,000 61,666,000,000 63,969,000,000 1,002,000,000 995,000,000 1,026,000,000 1,091,000,000 1,107,000,000 1,090,000,000 1,116,000,000 1,210,000,000 1,213,000,000 1,245,000,000 1,276,000,000 1,385,000,000 1,377,000,000 1,379,000,000 1,380,000,000 1,419,000,000 1,544,000,000 1,563,000,000 1,706,000,000 1,753,000,000 1,718,000,000 1,843,000,000 2,208,000,000 2,318,000,000 8,176,000,000 8,370,000,000 8,570,000,000 8,778,000,000 9,217,000,000 4,569,000,000 4,816,000,000 3,124,000,000 3,196,000,000 3,222,000,000 3,299,000,000 3,370,000,000 2,720,000,000 2,763,000,000 2,813,000,000 
        deferred income taxes
      5,176,000,000 5,378,000,000 4,961,000,000 4,647,000,000 3,997,000,000 4,236,000,000 3,609,000,000 3,323,000,000 2,723,000,000 2,768,000,000 1,514,000,000 1,572,000,000 1,317,000,000 1,344,000,000 1,329,000,000 1,337,000,000 1,418,000,000 1,439,000,000 684,000,000 650,000,000 793,000,000 1,161,000,000 913,000,000 1,088,000,000 605,000,000 510,000,000 1,624,000,000 1,442,000,000 1,380,000,000 1,371,000,000 1,627,000,000 1,517,000,000 1,367,000,000 1,610,000,000 2,346,000,000 2,572,000,000 2,618,000,000 2,996,000,000 3,528,000,000 3,389,000,000 3,230,000,000  1,731,000,000 1,892,000,000 1,885,000,000 1,644,000,000 1,510,000,000 1,356,000,000 1,390,000,000 1,701,000,000 2,036,000,000 1,960,000,000 1,828,000,000 1,597,000,000 1,339,000,000 1,175,000,000 1,160,000,000 1,200,000,000 1,276,000,000 1,134,000,000 1,143,000,000 1,036,000,000 1,071,000,000 796,000,000 745,000,000 
        other non-current assets
      6,082,000,000 6,474,000,000 6,332,000,000 5,936,000,000 5,866,000,000 6,105,000,000 6,044,000,000 6,071,000,000 6,024,000,000 5,370,000,000 5,214,000,000 5,022,000,000 4,868,000,000 4,940,000,000 4,745,000,000 4,728,000,000 4,845,000,000 5,535,000,000 7,403,000,000 6,454,000,000 7,137,000,000 7,019,000,000 6,896,000,000 6,596,000,000 5,946,000,000 6,604,000,000                                        
        total assets
      86,476,000,000 90,038,000,000 96,889,000,000 94,676,000,000 92,427,000,000 92,603,000,000 93,670,000,000 94,646,000,000 99,031,000,000 95,159,000,000 91,263,000,000 93,489,000,000 94,281,000,000 96,820,000,000 98,196,000,000 100,357,000,000 103,034,000,000 109,314,000,000 110,893,000,000 110,797,000,000 112,435,000,000 118,481,000,000 125,536,000,000 128,076,000,000 129,285,000,000 129,944,000,000 57,433,000,000 55,163,000,000 34,834,000,000 34,986,000,000 33,734,000,000 32,641,000,000 33,083,000,000 33,551,000,000 33,977,000,000 33,409,000,000 32,937,000,000 33,707,000,000 33,727,000,000 32,831,000,000 31,892,000,000 31,748,000,000 31,779,000,000 31,954,000,000 33,579,000,000 33,749,000,000 33,450,000,000 33,503,000,000 33,424,000,000 38,592,000,000 36,804,000,000 36,252,000,000 35,958,000,000 35,897,000,000 36,044,000,000 31,667,000,000 32,408,000,000 32,970,000,000 32,014,000,000 31,833,000,000 30,851,000,000 31,076,000,000 31,885,000,000 31,051,000,000 30,753,000,000 
        liabilities
                                                                       
        current liabilities:
                                                                       
        short-term debt obligations
      2,308,000,000 2,261,000,000 4,509,000,000 4,715,000,000 3,554,000,000 2,046,000,000 1,078,000,000 3,531,000,000 6,190,000,000 3,119,000,000 5,467,000,000 3,020,000,000 2,752,000,000 4,264,000,000 2,132,000,000 4,953,000,000 7,522,000,000 4,948,000,000 5,065,000,000 2,655,000,000 1,777,000,000 2,340,000,000 3,585,000,000 4,819,000,000 3,862,000,000 3,346,000,000 569,000,000 545,000,000 381,000,000 1,703,000,000 1,620,000,000 1,716,000,000 1,925,000,000 987,000,000 1,461,000,000 1,306,000,000 1,197,000,000                             
        accounts payable
      4,234,000,000 3,575,000,000 4,288,000,000 5,427,000,000 4,002,000,000 3,602,000,000 3,469,000,000 3,751,000,000 3,539,000,000 3,259,000,000 2,813,000,000 3,069,000,000 3,194,000,000 3,040,000,000 2,595,000,000 2,882,000,000 2,944,000,000 2,949,000,000 2,695,000,000 3,609,000,000 2,972,000,000 2,713,000,000 2,441,000,000 2,852,000,000 3,069,000,000 2,445,000,000 1,888,000,000 2,005,000,000 1,976,000,000 1,892,000,000 1,773,000,000 1,873,000,000 1,725,000,000 2,248,000,000 1,699,000,000 1,551,000,000 1,503,000,000 1,664,000,000 1,407,000,000 1,504,000,000 1,543,000,000 1,565,000,000 1,249,000,000 1,839,000,000 2,346,000,000 2,487,000,000 2,568,000,000 2,405,000,000 2,502,000,000 2,559,000,000 2,466,000,000 2,346,000,000 2,079,000,000 2,202,000,000 2,085,000,000 2,134,000,000 2,385,000,000 2,603,000,000 2,292,000,000 2,401,000,000 2,036,000,000 1,983,000,000 1,725,000,000 1,681,000,000 1,752,000,000 
        other current liabilities
      12,616,000,000 17,581,000,000 19,339,000,000 17,386,000,000 16,514,000,000 18,126,000,000 18,091,000,000 15,983,000,000 16,093,000,000 15,884,000,000 15,182,000,000 14,061,000,000 13,139,000,000 14,586,000,000 14,203,000,000 13,080,000,000 12,355,000,000 13,971,000,000 13,700,000,000 12,727,000,000 12,581,000,000 14,027,000,000 14,438,000,000 15,750,000,000 12,301,000,000 12,513,000,000                                        
        total current liabilities
      19,158,000,000 23,417,000,000 28,136,000,000 27,528,000,000 24,070,000,000 23,774,000,000 22,638,000,000 23,265,000,000 25,822,000,000 22,262,000,000 23,462,000,000 20,150,000,000 19,085,000,000 21,890,000,000 18,930,000,000 20,915,000,000 22,821,000,000 21,868,000,000 21,460,000,000 18,991,000,000 17,330,000,000 19,080,000,000 20,464,000,000 23,421,000,000 19,232,000,000 18,304,000,000 10,489,000,000 9,711,000,000 8,841,000,000 10,654,000,000 9,694,000,000 9,878,000,000 9,624,000,000 9,563,000,000 9,438,000,000 9,017,000,000 8,494,000,000 8,841,000,000 8,996,000,000 7,885,000,000 7,597,000,000 8,017,000,000 7,158,000,000 7,435,000,000 7,689,000,000 8,461,000,000 8,103,000,000 7,798,000,000 7,521,000,000 12,440,000,000 8,279,000,000 8,354,000,000 8,414,000,000 8,279,000,000 8,195,000,000 6,991,000,000 7,211,000,000 7,780,000,000 7,313,000,000 7,410,000,000 6,755,000,000 6,739,000,000 6,284,000,000 5,908,000,000 6,017,000,000 
        long-term debt
      42,152,000,000 42,850,000,000 44,469,000,000 44,470,000,000 46,157,000,000 47,603,000,000 48,674,000,000 48,858,000,000 49,487,000,000 36,653,000,000 32,137,000,000 34,656,000,000 35,078,000,000 35,056,000,000 36,966,000,000 37,107,000,000 37,450,000,000 39,605,000,000 39,677,000,000 42,503,000,000 44,505,000,000 48,336,000,000 41,364,000,000 41,853,000,000 42,844,000,000 43,387,000,000 24,390,000,000 24,433,000,000 5,635,000,000 5,646,000,000 5,687,000,000 5,671,000,000 5,775,000,000 6,975,000,000 6,982,000,000 6,911,000,000 7,237,000,000 5,716,000,000 5,836,000,000 6,581,000,000 6,593,000,000 6,550,000,000 6,632,000,000 6,615,000,000 7,127,000,000 7,242,000,000 7,267,000,000 7,372,000,000 7,367,000,000 7,981,000,000 6,532,000,000 6,442,000,000 6,522,000,000 6,568,000,000 6,608,000,000 5,209,000,000 5,270,000,000 5,376,000,000 5,437,000,000 5,332,000,000 5,276,000,000 5,328,000,000 6,479,000,000 6,248,000,000 6,081,000,000 
        other non-current liabilities
      4,853,000,000 5,043,000,000 5,459,000,000 4,942,000,000 4,477,000,000 4,469,000,000 4,728,000,000 4,993,000,000 6,732,000,000 6,421,000,000 6,203,000,000 5,902,000,000 6,664,000,000 6,590,000,000 6,685,000,000 6,640,000,000 7,309,000,000 7,334,000,000 7,516,000,000 7,498,000,000 7,692,000,000 7,776,000,000 7,565,000,000 7,485,000,000 10,701,000,000 10,101,000,000 1,881,000,000 1,897,000,000                                      
        total liabilities
      66,374,000,000 71,533,000,000 78,289,000,000 77,187,000,000 74,979,000,000 76,215,000,000 76,470,000,000 77,577,000,000 82,483,000,000 65,674,000,000 62,201,000,000 61,459,000,000 62,395,000,000 65,702,000,000 65,462,000,000 67,696,000,000 71,389,000,000 73,308,000,000 73,609,000,000 73,923,000,000 74,762,000,000 80,599,000,000 75,306,000,000 78,916,000,000 79,308,000,000 78,246,000,000 39,679,000,000 39,012,000,000 19,517,000,000 20,859,000,000 19,984,000,000 20,223,000,000 20,177,000,000 21,704,000,000 19,063,000,000 18,588,000,000 18,402,000,000 17,360,000,000 17,946,000,000 17,753,000,000 17,341,000,000 17,324,000,000 16,506,000,000 16,663,000,000 17,890,000,000 18,766,000,000 18,249,000,000 18,124,000,000 17,893,000,000 23,356,000,000 22,090,000,000 21,879,000,000 22,259,000,000 22,259,000,000 22,144,000,000 15,855,000,000 16,162,000,000 17,103,000,000 15,578,000,000 15,688,000,000 14,950,000,000 15,438,000,000 16,028,000,000 15,477,000,000 15,520,000,000 
        commitments and contingencies
                                                                       
        equity
                                                                       
        bms shareholders’ equity:
                                                                       
        preferred stock
                                                                       
        common stock
      292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 292,000,000 221,000,000 221,000,000 221,000,000 221,000,000 221,000,000 221,000,000 221,000,000 221,000,000 221,000,000 221,000,000 221,000,000 221,000,000    221,000,000    221,000,000    221,000,000   221,000,000 221,000,000 221,000,000 221,000,000 221,000,000 220,000,000 220,000,000 220,000,000 220,000,000 220,000,000 220,000,000 220,000,000 220,000,000 
        capital in excess of par value of stock
      46,374,000,000 46,387,000,000 46,265,000,000 46,134,000,000 46,011,000,000 46,024,000,000 45,896,000,000 45,766,000,000 45,655,000,000 45,684,000,000 44,849,000,000 45,299,000,000 45,140,000,000 45,165,000,000 44,956,000,000 44,375,000,000 43,756,000,000 44,361,000,000 44,292,000,000 44,064,000,000 43,852,000,000 44,325,000,000 44,435,000,000 44,444,000,000 43,254,000,000 43,709,000,000 2,206,000,000 2,150,000,000 2,103,000,000 2,081,000,000 2,029,000,000 1,966,000,000 1,916,000,000 1,898,000,000 1,845,000,000 1,794,000,000 1,337,000,000 1,725,000,000 1,650,000,000 1,594,000,000 1,503,000,000 1,459,000,000 1,413,000,000 1,363,000,000 1,314,000,000 1,507,000,000 1,499,000,000 1,479,000,000 1,449,000,000 1,922,000,000 1,966,000,000 1,975,000,000 2,126,000,000 2,694,000,000 2,717,000,000 2,783,000,000 2,825,000,000 3,114,000,000 3,226,000,000 3,321,000,000 3,436,000,000 3,682,000,000 3,661,000,000 3,697,000,000 3,676,000,000 
        accumulated other comprehensive loss
      -1,370,000,000 -1,524,000,000 -1,513,000,000 -1,554,000,000 -1,424,000,000 -1,238,000,000 -1,468,000,000 -1,456,000,000 -1,400,000,000 -1,546,000,000 -1,286,000,000 -1,387,000,000 -1,368,000,000 -1,281,000,000 -841,000,000 -992,000,000 -1,229,000,000 -1,268,000,000 -1,424,000,000 -1,518,000,000 -1,544,000,000 -1,839,000,000 -1,699,000,000 -1,556,000,000 -1,549,000,000 -1,520,000,000 -1,463,000,000 -2,621,000,000 -2,644,000,000 -2,762,000,000 -2,326,000,000 -2,334,000,000 -2,234,000,000 -2,289,000,000 -2,421,000,000 -2,467,000,000 -2,414,000,000 -2,503,000,000 -2,735,000,000 -2,804,000,000 -2,693,000,000 -2,468,000,000 -2,395,000,000 -2,173,000,000 -2,416,000,000 -2,425,000,000 -2,605,000,000 -2,225,000,000 -2,267,000,000 -2,141,000,000 -2,312,000,000 -2,520,000,000 -3,131,000,000 -3,202,000,000 -2,944,000,000 -2,967,000,000 -3,018,000,000 -3,045,000,000 -2,282,000,000 -2,389,000,000 -2,414,000,000 -2,371,000,000 -2,334,000,000 -2,300,000,000 -2,425,000,000 
        retained earnings
      18,287,000,000 16,896,000,000 17,093,000,000 16,154,000,000 16,106,000,000 14,912,000,000 16,097,000,000 16,103,000,000 15,640,000,000 28,766,000,000 28,218,000,000 27,449,000,000 26,568,000,000 25,503,000,000 24,675,000,000 24,217,000,000 23,948,000,000 23,820,000,000 22,625,000,000 22,168,000,000 22,204,000,000 21,281,000,000 32,414,000,000 31,565,000,000 32,671,000,000 34,474,000,000 36,555,000,000 35,870,000,000 35,109,000,000 34,065,000,000 33,292,000,000 32,044,000,000 32,323,000,000 31,160,000,000 34,141,000,000 33,934,000,000 33,658,000,000 33,513,000,000 33,272,000,000 32,706,000,000 32,176,000,000 31,613,000,000 32,446,000,000 32,361,000,000 33,110,000,000 32,541,000,000 33,147,000,000 33,026,000,000 33,291,000,000 32,952,000,000 32,826,000,000 32,715,000,000 32,761,000,000 32,733,000,000 32,381,000,000 33,661,000,000 33,595,000,000 33,069,000,000 32,797,000,000 32,392,000,000 32,055,000,000 31,636,000,000 31,721,000,000 31,322,000,000 30,949,000,000 
        less cost of treasury stock
      -43,515,000,000  -43,586,000,000 -43,590,000,000 -43,597,000,000  -43,675,000,000 -43,690,000,000 -43,697,000,000  -43,075,000,000 -39,680,000,000 -38,808,000,000  -36,411,000,000 -35,292,000,000 -35,187,000,000  -28,572,000,000 -28,198,000,000 -27,199,000,000  -25,284,000,000 -25,651,000,000 -24,757,000,000  -19,871,000,000 -19,571,000,000 -19,571,000,000  -19,576,000,000 -19,580,000,000 -19,433,000,000  -19,003,000,000 -18,783,000,000 -18,386,000,000                             
        total bms shareholders’ equity
      20,068,000,000 18,473,000,000 18,552,000,000 17,435,000,000 17,389,000,000 16,335,000,000 17,142,000,000 17,015,000,000 16,490,000,000 29,430,000,000 28,998,000,000 31,973,000,000 31,824,000,000                                                     
        noncontrolling interest
      34,000,000 33,000,000 48,000,000 54,000,000 59,000,000 53,000,000 58,000,000 54,000,000 58,000,000 55,000,000 64,000,000 57,000,000 62,000,000 57,000,000 63,000,000 61,000,000 65,000,000 60,000,000 71,000,000 66,000,000 68,000,000 60,000,000 72,000,000 66,000,000 66,000,000 100,000,000 106,000,000 102,000,000 99,000,000 96,000,000 110,000,000 101,000,000 113,000,000 106,000,000 131,000,000 122,000,000 119,000,000 170,000,000 168,000,000 160,000,000 165,000,000 158,000,000 194,000,000 168,000,000 143,000,000 131,000,000 58,000,000 52,000,000 58,000,000 82,000,000 -12,000,000 2,000,000 40,000,000 15,000,000  -286,000,000 -91,000,000 -89,000,000 -136,000,000 -208,000,000 -97,000,000 -75,000,000 -113,000,000 -94,000,000 -16,000,000 
        total equity
      20,102,000,000 18,506,000,000 18,600,000,000 17,489,000,000 17,448,000,000 16,388,000,000 17,200,000,000 17,069,000,000 16,548,000,000 29,485,000,000 29,062,000,000 32,030,000,000 31,886,000,000 31,118,000,000 32,734,000,000 32,661,000,000 31,645,000,000 36,006,000,000 37,284,000,000 36,874,000,000 37,673,000,000 37,882,000,000 50,230,000,000 49,160,000,000 49,977,000,000 51,698,000,000 17,754,000,000 16,151,000,000 15,317,000,000 14,127,000,000 13,750,000,000 12,418,000,000 12,906,000,000 11,847,000,000 14,914,000,000 14,821,000,000 14,535,000,000 16,347,000,000 15,781,000,000 15,078,000,000 14,551,000,000 14,424,000,000 15,273,000,000 15,291,000,000 15,689,000,000 14,983,000,000 15,201,000,000 15,379,000,000 15,531,000,000 15,236,000,000 14,714,000,000 14,373,000,000 13,699,000,000 13,638,000,000 13,900,000,000 15,812,000,000 16,246,000,000 15,867,000,000 16,436,000,000 16,145,000,000 15,901,000,000 15,638,000,000 15,857,000,000 15,574,000,000 15,233,000,000 
        total liabilities and equity
      86,476,000,000 90,038,000,000 96,889,000,000 94,676,000,000 92,427,000,000 92,603,000,000 93,670,000,000 94,646,000,000 99,031,000,000 95,159,000,000 91,263,000,000 93,489,000,000 94,281,000,000 96,820,000,000 98,196,000,000 100,357,000,000 103,034,000,000 109,314,000,000 110,893,000,000 110,797,000,000 112,435,000,000 118,481,000,000 125,536,000,000 128,076,000,000 129,285,000,000 129,944,000,000 57,433,000,000 55,163,000,000 34,834,000,000 34,986,000,000 33,734,000,000 32,641,000,000 33,083,000,000 33,551,000,000 33,977,000,000 33,409,000,000 32,937,000,000 33,707,000,000 33,727,000,000 32,831,000,000 31,892,000,000 31,748,000,000 31,779,000,000 31,954,000,000 33,579,000,000 33,749,000,000 33,450,000,000 33,503,000,000 33,424,000,000 38,592,000,000 36,804,000,000 36,252,000,000 35,958,000,000 35,897,000,000 36,044,000,000 31,667,000,000 32,408,000,000 32,970,000,000 32,014,000,000 31,833,000,000 30,851,000,000 31,076,000,000 31,885,000,000 31,051,000,000 30,753,000,000 
        bristol-myers squibb company shareholders’ equity:
                                                                       
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 2,510 in 2025 and 2,868 in 2024, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 887 million common shares in 2025 and 894 million common shares in 2024
       -43,579,000,000                                                                
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 2,868 in 2024 and 2,953 in 2023, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 894 million common shares in 2024 and 902 million common shares in 2023
           -43,655,000,000                                                            
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 2,953 in 2023 and 2,991 in 2022, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 902 million common shares in 2023 and 825 million common shares in 2022
               -43,766,000,000                                                        
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 2,991 in 2022 and 3,484 in 2021, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 825 million common shares in 2022 and 747 million common shares in 2021
                   -38,618,000,000                                                    
        total bristol-myers squibb company shareholders’ equity
                   31,061,000,000 32,671,000,000 32,600,000,000 31,580,000,000 35,946,000,000 37,213,000,000 36,808,000,000 37,605,000,000 37,822,000,000 50,158,000,000 49,094,000,000 49,911,000,000  17,648,000,000 16,049,000,000 15,218,000,000  13,640,000,000 12,317,000,000 12,793,000,000  14,783,000,000 14,699,000,000 14,416,000,000  15,613,000,000 14,918,000,000 14,386,000,000  15,079,000,000 15,123,000,000 15,546,000,000  15,143,000,000 15,327,000,000 15,473,000,000  14,726,000,000 14,371,000,000 13,659,000,000 13,623,000,000 13,900,000,000 16,098,000,000 16,337,000,000 15,956,000,000 16,572,000,000 16,353,000,000 15,998,000,000 15,713,000,000 15,970,000,000 15,668,000,000 15,249,000,000 
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 3,484 in 2021 and 3,484 in 2020, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 747 million common shares in 2021 and 679 million common shares in 2020
                       -31,259,000,000                                                
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 3,484 in 2020 and 3,568 in 2019, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 679 million common shares in 2020 and 672 million common shares in 2019
                           -26,237,000,000                                            
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 3,568 in 2019 and 3,590 in 2018, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 672 million common shares in 2019 and 576 million common shares in 2018
                               -25,357,000,000                                        
        total bristol-myers squibb company shareholders' equity
                               51,598,000,000    14,031,000,000    11,741,000,000    16,177,000,000    14,266,000,000    14,852,000,000    15,154,000,000                
        marketable securities
                                2,053,000,000 953,000,000 1,429,000,000 1,973,000,000 1,422,000,000 1,076,000,000 1,428,000,000 1,391,000,000 2,478,000,000 3,035,000,000 2,199,000,000 2,113,000,000 2,128,000,000 1,717,000,000 1,663,000,000 1,885,000,000 1,438,000,000 1,277,000,000 1,313,000,000 1,864,000,000 2,370,000,000 2,893,000,000 1,834,000,000 939,000,000 951,000,000 978,000,000 1,178,000,000 1,173,000,000 1,427,000,000 2,236,000,000 2,722,000,000 2,957,000,000 3,722,000,000 4,005,000,000 3,388,000,000 2,268,000,000 778,000,000 1,536,000,000 1,641,000,000 
        prepaid expenses and other
                                947,000,000 1,384,000,000 1,342,000,000 1,116,000,000 886,000,000 998,000,000 965,000,000 576,000,000 754,000,000 820,000,000 628,000,000 570,000,000 565,000,000 588,000,000 615,000,000 491,000,000 529,000,000 502,000,000 538,000,000 470,000,000 482,000,000 512,000,000 538,000,000 412,000,000 556,000,000 536,000,000 616,000,000 355,000,000 423,000,000 455,000,000 500,000,000 258,000,000 356,000,000 420,000,000 451,000,000     
        other assets
                                2,348,000,000 2,634,000,000 2,581,000,000 2,024,000,000 2,336,000,000 2,280,000,000 1,776,000,000 1,533,000,000 965,000,000 883,000,000 848,000,000 1,048,000,000 918,000,000 1,012,000,000 1,048,000,000 1,117,000,000 762,000,000 787,000,000 634,000,000 621,000,000 779,000,000 1,363,000,000 1,324,000,000 1,428,000,000 1,301,000,000 1,104,000,000 975,000,000 904,000,000 877,000,000 875,000,000 823,000,000 824,000,000 741,000,000 794,000,000 767,000,000 1,005,000,000 1,207,000,000 1,216,000,000 976,000,000 
        accrued and other current liabilities
                                8,032,000,000 7,161,000,000                                      
        income taxes payable
                                2,919,000,000 2,971,000,000 525,000,000 398,000,000 355,000,000 373,000,000 296,000,000 231,000,000 213,000,000 291,000,000 180,000,000 152,000,000 312,000,000 164,000,000 472,000,000 572,000,000 179,000,000 98,000,000 220,000,000 262,000,000 312,000,000 204,000,000 170,000,000 160,000,000 208,000,000 212,000,000              
        accrued liabilities
                                  5,856,000,000 6,489,000,000 5,853,000,000 5,828,000,000 5,561,000,000 6,014,000,000 5,418,000,000 5,132,000,000 4,777,000,000 5,271,000,000 4,964,000,000 4,880,000,000 4,311,000,000                         
        deferred income
                                  103,000,000 172,000,000 93,000,000 88,000,000 117,000,000 83,000,000 647,000,000 737,000,000 837,000,000 762,000,000 1,323,000,000 1,182,000,000 1,165,000,000 1,003,000,000 963,000,000 939,000,000 1,459,000,000 1,167,000,000 995,000,000 1,090,000,000 1,061,000,000 756,000,000 1,003,000,000 986,000,000 772,000,000 825,000,000 689,000,000 357,000,000 287,000,000 337,000,000 321,000,000 283,000,000 347,000,000 402,000,000 289,000,000 275,000,000 265,000,000 
        pension and other liabilities
                                  1,509,000,000 1,048,000,000 1,005,000,000 1,066,000,000 1,098,000,000 1,164,000,000 1,155,000,000 1,181,000,000 1,195,000,000 1,283,000,000 1,642,000,000 1,805,000,000 1,693,000,000                         
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 3,590 in 2018 and 4,070 in 2017, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 576 million common shares in 2018 and 575 million common shares in 2017
                                   -19,574,000,000                                    
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 4,070 in 2017 and 4,129 in 2016, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 575 million common shares in 2017 and 536 million in 2016
                                       -19,249,000,000                                
        short-term borrowings and current portion of long-term debt
                                           992,000,000 990,000,000        401,000,000 365,000,000 281,000,000 359,000,000 680,000,000 764,000,000 1,372,000,000 826,000,000 751,000,000           
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 4,129 in 2016 and 4,161 in 2015, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 536 million common shares in 2016 and 539 million in 2015
                                           -16,779,000,000                            
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; 4,161 issued
                                                                       
        and outstanding in both 2016 and 2015, liquidation value of 50 per share
                                                                       
        and 2015
                                            221,000,000 221,000,000 221,000,000                         
        less cost of treasury stock – 537 million common shares in 2016 and 539 million in 2015
                                            -16,795,000,000 -16,799,000,000                          
        short-term borrowings
                                             155,000,000 106,000,000 139,000,000 642,000,000 755,000,000 330,000,000 590,000,000          236,000,000 145,000,000 115,000,000 182,000,000 187,000,000 135,000,000 117,000,000 243,000,000 290,000,000 208,000,000 
        less cost of treasury stock – 539 million common shares in both 2016 and 2015
                                              -16,821,000,000                         
        assets
                                                                       
        assets held-for-sale
                                               134,000,000 215,000,000 210,000,000  109,000,000 78,000,000 38,000,000 56,000,000 7,420,000,000                
        accrued expenses
                                               2,759,000,000 2,330,000,000 2,103,000,000 1,791,000,000 2,459,000,000 2,290,000,000 2,204,000,000 1,997,000,000 2,152,000,000 2,277,000,000 2,423,000,000 2,376,000,000 2,573,000,000 2,759,000,000 2,467,000,000 2,566,000,000 2,791,000,000 2,699,000,000 2,828,000,000 2,661,000,000 2,740,000,000 2,684,000,000 2,386,000,000 2,477,000,000 
        accrued rebates and returns
                                               1,324,000,000 1,159,000,000 1,067,000,000 910,000,000 851,000,000 914,000,000 909,000,000 891,000,000 889,000,000 1,034,000,000 1,017,000,000 938,000,000 1,054,000,000 1,122,000,000 1,061,000,000 1,073,000,000 1,170,000,000 1,058,000,000 967,000,000 935,000,000 857,000,000 741,000,000 671,000,000 660,000,000 
        dividends payable
                                               655,000,000 636,000,000 634,000,000 633,000,000 645,000,000 623,000,000 621,000,000 619,000,000 634,000,000 611,000,000 606,000,000 601,000,000 606,000,000 596,000,000 598,000,000 593,000,000 597,000,000 578,000,000 579,000,000 578,000,000 575,000,000 556,000,000 556,000,000 554,000,000 
        pension, postretirement and postemployment liabilities
                                               949,000,000 902,000,000 727,000,000 1,156,000,000 1,115,000,000 806,000,000 681,000,000 690,000,000 718,000,000 773,000,000 826,000,000 1,638,000,000 1,882,000,000 1,473,000,000 1,543,000,000 1,616,000,000 2,017,000,000 811,000,000 870,000,000 922,000,000 1,297,000,000 1,209,000,000 1,248,000,000 1,300,000,000 
        other liabilities
                                               480,000,000 468,000,000 475,000,000 583,000,000 618,000,000 618,000,000 624,000,000 616,000,000 625,000,000 665,000,000 649,000,000 459,000,000 475,000,000 464,000,000 703,000,000 656,000,000 491,000,000 467,000,000 443,000,000 438,000,000 424,000,000 409,000,000 409,000,000 416,000,000 
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 4,161 in 2015 and 4,212 in 2014, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 539 million common shares in 2015 and 547 million in 2014
                                               -16,559,000,000                        
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued
                                                                       
        and outstanding 4,178 in 2015 and 4,212 in 2014, liquidation value of 50 per share
                                                                       
        and 2014
                                                221,000,000 221,000,000 221,000,000                     
        less cost of treasury stock – 540 million common shares in 2015 and 547 million in 2014
                                                -16,606,000,000                       
        less cost of treasury stock – 541 million common shares in 2015 and 547 million in 2014
                                                 -16,649,000,000 -16,683,000,000                     
        and outstanding 4,191 in 2015 and 4,212 in 2014, liquidation value of 50 per share
                                                                       
        liabilities related to assets held-for-sale
                                                       4,931,000,000                
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 4,212 in 2014 and 4,369 in 2013, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 547 million common shares in 2014 and 559 million in 2013
                                                   -16,992,000,000                    
        and outstanding 4,227 in 2014 and 4,369 in 2013, liquidation value of 50 per share
                                                                       
        and 2013
                                                    221,000,000 221,000,000 221,000,000                 
        less cost of treasury stock – 549 million common shares in 2014 and 559 million in 2013
                                                    -17,119,000,000                   
        and outstanding 4,237 in 2014 and 4,369 in 2013, liquidation value of 50 per share
                                                                       
        less cost of treasury stock – 550 million common shares in 2014 and 559 million in 2013
                                                     -17,174,000,000                  
        and outstanding 4,252 in 2014 and 4,369 in 2013, liquidation value of 50 per share
                                                                       
        less cost of treasury stock – 551 million common shares in 2014 and 559 million in 2013
                                                      -17,221,000,000                 
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 4,369 in 2013 and 5,117 in 2012, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 559 million common shares in 2013 and 570 million in 2012
                                                       -17,800,000,000                
        and outstanding 4,445 in 2013 and 5,189 in 2012, liquidation value of 50 per share
                                                                       
        both 2013 and 2012
                                                        221,000,000 221,000,000              
        less cost of treasury stock – 561 million common shares in 2013 and 570 million in 2012
                                                        -17,975,000,000               
        and outstanding 4,485 in 2013 and 5,117 in 2012, liquidation value of 50 per share
                                                                       
        less cost of treasury stock – 562 million common shares in 2013 and 570 million in 2012
                                                         -18,020,000,000              
        u.s. and foreign income taxes payable
                                                          276,000,000 193,000,000 193,000,000 138,000,000 162,000,000 167,000,000 183,000,000 165,000,000 63,000,000 65,000,000 46,000,000 49,000,000 101,000,000 
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,085 in 2013 and 5,117 in 2012, liquidation value of 50 per share
                                                                       
        less cost of treasury stock – 565 million common shares in 2013 and 570 million in 2012
                                                          -18,318,000,000             
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,117 in 2012 and 5,268 in 2011, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 570 million common shares in 2012 and 515 million in 2011
                                                           -18,823,000,000            
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,189 in 2012 and 5,268 in 2011, liquidation value of 50 per share
                                                                       
        less cost of treasury stock – 558 million shares in 2012 and 515 million in 2011
                                                            -18,475,000,000           
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,238 in 2012 and 5,268 in 2011, liquidation value of 50 per share
                                                                       
        less cost of treasury stock – 530 million common shares in 2012 and 515 million in 2011
                                                             -17,600,000,000          
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,253 in 2012 and 5,268 in 2011, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 517 million common shares in 2012 and 515 million in 2011
                                                              -17,286,000,000         
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,268 in 2011 and 5,269 in 2010, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 515 million common shares in 2011 and 501 million in 2010
                                                               -17,402,000,000        
        less cost of treasury stock — 511 million common shares in 2011 and 501 million in 2010
                                                                -17,389,000,000       
        and outstanding 5,268 in 2011 and 5,269 in 2010, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 500 million common shares in 2011 and 501 million in 2010
                                                                 -17,191,000,000      
        less cost of treasury stock — 499 million common shares in 2011 and 501 million in 2010
                                                                  -17,299,000,000     
        prepaid expenses
                                                                   252,000,000 292,000,000 296,000,000 268,000,000 
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,269 in 2010 and 5,515 in 2009, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 501 million common shares in 2010 and 491 million in 2009
                                                                   -17,454,000,000    
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,279 in 2010 and 5,515 in 2009, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 494 million common shares in 2010 and 491 million in 2009
                                                                    -17,298,000,000   
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,366 in 2010 and 5,515 in 2009, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 491 million common shares in both 2010 and 2009
                                                                     -17,271,000,000  
        preferred stock, 2 convertible series, par value 1 per share: authorized 10 million shares; issued and outstanding 5,402 in 2010 and 5,515 in 2009, liquidation value of 50 per share
                                                                       
        less cost of treasury stock — 485 million common shares in 2010 and 491 million in 2009
                                                                      -17,171,000,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 
                                                                         
          cash flows from operating activities:
                                                                         
          net earnings
        2,678,000,000 1,085,000,000 2,195,000,000 1,313,000,000 2,462,000,000 76,000,000 1,215,000,000 1,684,000,000 -11,908,000,000 1,762,000,000 1,934,000,000 2,077,000,000 2,267,000,000 2,025,000,000 1,608,000,000 1,429,000,000 1,283,000,000 2,372,000,000 1,552,000,000 1,061,000,000 2,029,000,000 -10,027,000,000 1,878,000,000 -80,000,000 -766,000,000 -1,060,000,000 1,366,000,000 1,439,000,000 1,715,000,000 1,158,000,000 1,912,000,000 382,000,000 1,495,000,000 -2,329,000,000 856,000,000 922,000,000 1,526,000,000 898,000,000 1,215,000,000 1,188,000,000 1,206,000,000 -188,000,000 730,000,000 -110,000,000 1,199,000,000 27,000,000 732,000,000 334,000,000 936,000,000 735,000,000 692,000,000 530,000,000 623,000,000 924,000,000 -713,000,000 808,000,000 1,482,000,000 1,231,000,000 1,355,000,000 1,307,000,000 1,367,000,000 842,000,000 1,302,000,000 1,268,000,000 1,101,000,000 
          adjustments to reconcile net earnings to net cash from operating activities:
                                                                         
          depreciation and amortization
        594,000,000 977,000,000 1,011,000,000 1,011,000,000 1,012,000,000 1,880,000,000 2,592,000,000 2,596,000,000 2,532,000,000 2,464,000,000 2,435,000,000 2,432,000,000 2,429,000,000 2,521,000,000 2,588,000,000 2,583,000,000 2,584,000,000 2,579,000,000 2,727,000,000 2,712,000,000 2,668,000,000 2,690,000,000 2,655,000,000 2,558,000,000 2,477,000,000 1,236,000,000 171,000,000 169,000,000 170,000,000 172,000,000 165,000,000 157,000,000 143,000,000 197,000,000 188,000,000 211,000,000 193,000,000 122,000,000 105,000,000 90,000,000 65,000,000 76,000,000 105,000,000 91,000,000 104,000,000 103,000,000 112,000,000 115,000,000 137,000,000 181,000,000 180,000,000 189,000,000 213,000,000 199,000,000            
          deferred income taxes
        161,000,000 -392,000,000 -359,000,000 -437,000,000 223,000,000 -791,000,000 -256,000,000 -331,000,000 -711,000,000 -1,327,000,000 -327,000,000 -1,086,000,000 -548,000,000 -624,000,000 -645,000,000 -782,000,000 -687,000,000 -1,266,000,000 -32,000,000 -163,000,000 68,000,000 -436,000,000 54,000,000 1,418,000,000 -53,000,000 -337,000,000 -500,000,000 -89,000,000 2,000,000 247,000,000 -124,000,000 -197,000,000 160,000,000 727,000,000 262,000,000 91,000,000 -70,000,000 296,000,000 -183,000,000 -71,000,000 -246,000,000 -398,000,000 110,000,000 -52,000,000 -7,000,000 -485,000,000 -93,000,000 -74,000,000 110,000,000 -82,000,000 -74,000,000 -153,000,000 -182,000,000 -493,000,000         3,000,000 7,000,000 90,000,000 
          stock-based compensation
        146,000,000 133,000,000 139,000,000 137,000,000 144,000,000 120,000,000 129,000,000 125,000,000 133,000,000 127,000,000 132,000,000 137,000,000 122,000,000 119,000,000 115,000,000 116,000,000 107,000,000 133,000,000 142,000,000 157,000,000 151,000,000 171,000,000 185,000,000 213,000,000 210,000,000 284,000,000 56,000,000 48,000,000 53,000,000 53,000,000 62,000,000 51,000,000 55,000,000 50,000,000 50,000,000 54,000,000 45,000,000 56,000,000 48,000,000 54,000,000 47,000,000 59,000,000 63,000,000 59,000,000 54,000,000 66,000,000 48,000,000 50,000,000 49,000,000 51,000,000 45,000,000 46,000,000 49,000,000 46,000,000         47,000,000 49,000,000 47,000,000 
          impairment charges
        412,000,000 584,000,000 196,000,000   1,953,000,000 139,000,000 870,000,000 1,000,000 29,000,000 159,000,000 47,000,000 20,000,000 35,000,000 61,000,000 42,000,000 41,000,000 15,000,000 613,000,000 240,000,000 339,000,000 1,072,000,000 15,000,000 63,000,000 53,000,000 16,000,000 9,000,000 129,000,000 45,000,000 16,000,000 6,000,000 24,000,000 80,000,000 109,000,000 4,000,000 141,000,000 78,000,000 33,000,000 7,000,000 49,000,000 19,000,000 168,000,000 4,000,000 7,000,000 13,000,000 15,000,000 28,000,000 311,000,000 47,000,000 34,000,000 2,000,000 1,000,000 3,000,000 62,000,000 1,830,000,000 192,000,000 96,000,000 13,000,000 15,000,000     
          divestiture gains and royalties
        -34,000,000 -285,000,000 -295,000,000 -293,000,000 -292,000,000 -281,000,000 -288,000,000 -270,000,000 -280,000,000 -245,000,000 -222,000,000 -223,000,000 -194,000,000 -243,000,000 -208,000,000 -225,000,000 -387,000,000 -222,000,000 -160,000,000 -167,000,000 -135,000,000 -213,000,000 -191,000,000 -122,000,000 -173,000,000 -179,000,000 -1,356,000,000 -154,000,000 -166,000,000 -170,000,000 -325,000,000 -242,000,000 -255,000,000 -160,000,000 -135,000,000 -135,000,000 -276,000,000 -105,000,000 -155,000,000 -420,000,000 -507,000,000                         
          acquired iprd
        94,000,000 1,393,000,000 633,000,000 1,507,000,000 188,000,000 30,000,000 262,000,000 132,000,000 12,949,000,000 600,000,000 80,000,000 158,000,000 75,000,000 52,000,000 30,000,000 400,000,000 333,000,000                                                 
          equity investment losses
        -134,000,000 -190,000,000 -190,000,000 22,000,000 78,000,000 205,000,000 -12,000,000 -107,000,000 -102,000,000 -53,000,000 58,000,000 155,000,000   308,000,000 644,000,000    -601,000,000 -504,000,000   339,000,000 -294,000,000 261,000,000                                       
          other adjustments
        21,000,000 308,000,000 -74,000,000 -12,000,000 10,000,000 -29,000,000 103,000,000 -2,000,000 22,000,000 48,000,000 269,000,000 -13,000,000 4,000,000 54,000,000 -40,000,000 -30,000,000 248,000,000 -26,000,000 -36,000,000 -29,000,000 233,000,000 -37,000,000 -48,000,000 -50,000,000 -42,000,000 -1,000,000 -7,000,000 -8,000,000 -6,000,000 -1,000,000 -16,000,000 2,000,000 -29,000,000 -16,000,000 9,000,000 66,000,000 33,000,000 12,000,000 -32,000,000 -14,000,000 -10,000,000 288,000,000 -365,000,000                       
          changes in operating assets and liabilities:
                                                                         
          receivables
        1,687,000,000 19,000,000 155,000,000 -484,000,000 15,000,000 143,000,000 661,000,000 -1,019,000,000 479,000,000 -508,000,000 -247,000,000 -65,000,000 -175,000,000 -106,000,000 -674,000,000 -669,000,000 786,000,000 -168,000,000 -260,000,000 -693,000,000 67,000,000 -290,000,000 -159,000,000 546,000,000 -743,000,000 318,000,000 127,000,000 71,000,000 236,000,000 -207,000,000 -334,000,000 -107,000,000 219,000,000 108,000,000 -85,000,000 -208,000,000 -246,000,000 93,000,000 -44,000,000 -428,000,000 -424,000,000 -356,000,000 -319,000,000 -176,000,000 -91,000,000 -186,000,000 -35,000,000 24,000,000 -55,000,000 59,000,000 -159,000,000 -86,000,000 -318,000,000 5,000,000 99,000,000 652,000,000 -108,000,000 -68,000,000 176,000,000 -237,000,000 -91,000,000 -148,000,000 -68,000,000 255,000,000 -309,000,000 
          inventories
        14,000,000 71,000,000 -90,000,000 4,000,000 -169,000,000 175,000,000 -218,000,000 -225,000,000 -218,000,000 -197,000,000 -256,000,000 -16,000,000 -282,000,000 -41,000,000 -16,000,000 -13,000,000 1,000,000 -128,000,000 30,000,000 5,000,000 106,000,000 101,000,000 481,000,000 642,000,000 1,448,000,000 470,000,000 -35,000,000 -7,000,000 35,000,000 -64,000,000 -30,000,000 -118,000,000 -4,000,000 -36,000,000 65,000,000 13,000,000 -71,000,000 -45,000,000 4,000,000 -67,000,000 -44,000,000 -134,000,000 69,000,000 111,000,000 51,000,000 -92,000,000 -5,000,000 -13,000,000 -144,000,000 -37,000,000 165,000,000 -10,000,000 -163,000,000 32,000,000 35,000,000 -102,000,000 -68,000,000 -43,000,000 96,000,000 -162,000,000 -84,000,000 193,000,000 -49,000,000 -13,000,000 25,000,000 
          accounts payable
        409,000,000 -90,000,000 160,000,000 13,000,000 -85,000,000 517,000,000 -374,000,000 -259,000,000 300,000,000 444,000,000 -268,000,000 -165,000,000 187,000,000 405,000,000 -300,000,000 -19,000,000 23,000,000 226,000,000 -139,000,000 -145,000,000 303,000,000 132,000,000 -424,000,000 -223,000,000 703,000,000 181,000,000 -108,000,000 20,000,000 136,000,000 127,000,000 -85,000,000 140,000,000 -241,000,000 257,000,000 148,000,000 29,000,000 -114,000,000 246,000,000 -106,000,000 41,000,000 -77,000,000 299,000,000 -600,000,000 -535,000,000 -83,000,000 -107,000,000 175,000,000 -100,000,000 -12,000,000 111,000,000 98,000,000 256,000,000 -53,000,000 89,000,000 -99,000,000 -254,000,000 32,000,000 284,000,000 -103,000,000 350,000,000 62,000,000 238,000,000 23,000,000 -65,000,000 119,000,000 
          rebates and discounts
        -3,495,000,000 -2,398,000,000 1,703,000,000 881,000,000 -627,000,000 -405,000,000 1,819,000,000 735,000,000 -665,000,000 -211,000,000 1,533,000,000 492,000,000 -910,000,000 -303,000,000 1,140,000,000 520,000,000 -930,000,000                                                 
          income taxes payable
        187,000,000 -324,000,000 887,000,000 -621,000,000 54,000,000 121,000,000 -348,000,000 -1,943,000,000 910,000,000 1,044,000,000 -412,000,000 -2,119,000,000 884,000,000 -1,113,000,000 60,000,000 -1,201,000,000 831,000,000 -222,000,000 -46,000,000 -1,022,000,000 227,000,000 -201,000,000 -2,289,000,000 -44,000,000 229,000,000 860,000,000 112,000,000 -261,000,000 196,000,000 -37,000,000 -17,000,000 102,000,000 114,000,000 2,197,000,000 -65,000,000 51,000,000 414,000,000 -283,000,000 253,000,000 -520,000,000 5,000,000 -30,000,000 53,000,000 -57,000,000 81,000,000 89,000,000 273,000,000 24,000,000 -215,000,000 -2,000,000 159,000,000               
          other
        -1,636,000,000 1,068,000,000 240,000,000 222,000,000 -1,059,000,000 725,000,000 167,000,000 340,000,000 -608,000,000 283,000,000 -59,000,000 173,000,000 -1,064,000,000 700,000,000 -46,000,000 -191,000,000 -1,073,000,000 -627,000,000 1,065,000,000 442,000,000 -1,137,000,000 104,000,000 1,105,000,000 220,000,000 -355,000,000 17,000,000 899,000,000 718,000,000 -932,000,000 826,000,000 129,000,000 374,000,000 -695,000,000 226,000,000 154,000,000 170,000,000 -777,000,000 567,000,000 29,000,000 298,000,000 -794,000,000    -832,000,000 -17,000,000 102,000,000 96,000,000 -214,000,000 2,000,000 -8,000,000 -3,000,000 -56,000,000 8,000,000 3,000,000 10,000,000 80,000,000 -25,000,000 -2,000,000 -111,000,000     
          net cash from operating activities
        1,104,000,000 1,974,000,000 6,311,000,000 3,917,000,000 1,954,000,000 4,439,000,000 5,591,000,000 2,326,000,000 2,834,000,000 4,252,000,000 4,751,000,000 1,887,000,000 2,970,000,000 3,306,000,000 3,687,000,000 2,261,000,000 3,812,000,000 4,057,000,000 5,266,000,000 3,060,000,000 3,824,000,000 3,670,000,000 2,219,000,000 4,269,000,000 3,894,000,000 2,038,000,000 2,556,000,000 2,083,000,000 1,390,000,000 2,429,000,000 1,279,000,000 1,057,000,000 1,175,000,000 1,117,000,000 1,713,000,000 1,584,000,000 861,000,000 1,428,000,000 1,397,000,000 411,000,000 -386,000,000 611,000,000 524,000,000 71,000,000 626,000,000 572,000,000 903,000,000 1,056,000,000 617,000,000 1,410,000,000 1,053,000,000 1,510,000,000 -428,000,000 836,000,000 4,584,000,000 1,134,000,000 387,000,000 1,568,000,000 1,698,000,000 1,093,000,000 481,000,000 1,595,000,000 1,383,000,000 1,049,000,000 464,000,000 
          cash flows from investing activities:
                                                                         
          sale and maturities of marketable debt securities
        359,000,000 402,000,000 829,000,000 524,000,000 220,000,000 62,000,000 238,000,000 75,000,000 747,000,000 41,000,000 365,000,000 270,000,000 57,000,000 1,206,000,000 1,417,000,000 1,688,000,000 2,100,000,000 1,244,000,000 984,000,000 1,186,000,000 782,000,000 1,523,000,000 1,220,000,000 2,143,000,000 1,394,000,000                                         
          purchase of marketable debt securities
        -781,000,000 -78,000,000 -665,000,000 -621,000,000 -636,000,000 -371,000,000 -40,000,000 -84,000,000 -274,000,000 -717,000,000 -502,000,000 -355,000,000 -200,000,000 -26,000,000 -274,000,000 -1,578,000,000 -1,714,000,000 -2,070,000,000 -1,065,000,000 -1,041,000,000 -1,302,000,000 -1,024,000,000 -1,191,000,000 -1,222,000,000 -735,000,000                                         
          proceeds from sales of equity investments
        391,000,000 16,000,000 49,000,000 12,000,000 205,000,000 55,000,000 5,000,000                                                         
          capital expenditures
        -347,000,000 -370,000,000 -320,000,000 -361,000,000 -260,000,000 -378,000,000 -324,000,000 -262,000,000 -284,000,000 -330,000,000 -342,000,000 -259,000,000 -278,000,000 -346,000,000 -247,000,000 -272,000,000 -253,000,000 -320,000,000 -270,000,000 -210,000,000 -173,000,000 -283,000,000 -153,000,000 -131,000,000 -186,000,000 -251,000,000 -190,000,000 -191,000,000 -204,000,000 -290,000,000 -224,000,000 -198,000,000 -239,000,000 -254,000,000 -262,000,000 -248,000,000 -291,000,000 -371,000,000 -341,000,000 -261,000,000 -242,000,000 -234,000,000 -165,000,000 -136,000,000 -191,000,000 -107,000,000 -110,000,000 -118,000,000 -200,000,000 -124,000,000 -98,000,000 -115,000,000 -175,000,000 -137,000,000 -113,000,000 -123,000,000 -134,000,000 -84,000,000 -74,000,000 -75,000,000 -125,000,000 -89,000,000 -81,000,000 -129,000,000 
          free cash flows
        757,000,000 1,604,000,000 5,991,000,000 3,556,000,000 1,694,000,000 4,061,000,000 5,267,000,000 2,064,000,000 2,550,000,000 3,922,000,000 4,409,000,000 1,628,000,000 2,692,000,000 2,960,000,000 3,440,000,000 1,989,000,000 3,559,000,000 3,737,000,000 4,996,000,000 2,850,000,000 3,651,000,000 3,387,000,000 2,066,000,000 4,138,000,000 3,708,000,000 1,787,000,000 2,366,000,000 1,892,000,000 1,186,000,000 2,139,000,000 1,055,000,000 859,000,000 936,000,000 863,000,000 1,451,000,000 1,336,000,000 570,000,000 1,057,000,000 1,056,000,000 150,000,000 -628,000,000 611,000,000 290,000,000 -94,000,000 490,000,000 381,000,000 796,000,000 946,000,000 499,000,000 1,210,000,000 929,000,000 1,412,000,000 -543,000,000 661,000,000 4,447,000,000 1,021,000,000 264,000,000 1,434,000,000 1,614,000,000 1,019,000,000 406,000,000 1,470,000,000 1,294,000,000 968,000,000 335,000,000 
          divestiture and other proceeds
        312,000,000 279,000,000 279,000,000 270,000,000 243,000,000 333,000,000 255,000,000 270,000,000 241,000,000 241,000,000 247,000,000 194,000,000 227,000,000 490,000,000 221,000,000 192,000,000 402,000,000 178,000,000 188,000,000 -203,000,000 585,000,000 320,000,000 202,000,000 143,000,000 205,000,000 13,765,000,000 1,719,000,000 197,000,000 171,000,000 302,000,000 364,000,000 208,000,000 375,000,000 196,000,000 137,000,000 148,000,000 241,000,000 141,000,000 190,000,000 564,000,000 439,000,000                         
          acquisition and other payments, net of cash acquired
        -65,000,000 -1,707,000,000 -1,874,000,000 -285,000,000 -78,000,000 -47,000,000 -348,000,000 -1,373,000,000 -20,053,000,000 -581,000,000 -326,000,000 -184,000,000 -78,000,000 -116,000,000 -3,261,000,000 -467,000,000 -442,000,000 -152,000,000 -1,057,000,000 -366,000,000 -35,000,000 -12,663,000,000 -243,000,000 -153,000,000 -25,000,000                                         
          net cash from investing activities
        -131,000,000 -1,458,000,000 -1,702,000,000 -473,000,000 -499,000,000 -196,000,000 -219,000,000 -1,319,000,000 -19,618,000,000 -1,346,000,000 -410,000,000 -329,000,000 -210,000,000 1,213,000,000 -2,081,000,000 -289,000,000 95,000,000 401,000,000 -976,000,000 180,000,000 -143,000,000 -12,127,000,000 -165,000,000 780,000,000 653,000,000 -12,036,000,000 491,000,000 715,000,000 1,060,000,000 -336,000,000 -147,000,000 -348,000,000 -43,000,000 1,019,000,000 142,000,000 -1,024,000,000 -203,000,000 16,000,000 -368,000,000 406,000,000 1,426,000,000 -984,000,000 -62,000,000 -1,280,000,000 754,000,000 351,000,000 164,000,000 -1,511,000,000 2,212,000,000 -315,000,000   161,000,000 277,000,000 -4,203,000,000 226,000,000 -3,027,000,000 495,000,000 -163,000,000 -332,000,000 -1,437,000,000 -2,479,000,000 948,000,000 238,000,000 -2,519,000,000 
          cash flows from financing activities:
                                                                         
          other short-term financing obligations
        321,000,000 -406,000,000 5,000,000 58,000,000 368,000,000 -405,000,000 95,000,000                                                           
          repayments of long-term debt
        -500,000,000 -10,068,000,000 -229,000,000   -2,478,000,000                                      -676,000,000                 
          dividends
        -1,283,000,000 -1,262,000,000 -1,263,000,000 -1,262,000,000 -1,258,000,000 -1,218,000,000 -1,216,000,000 -1,217,000,000 -1,212,000,000 -1,160,000,000 -1,191,000,000 -1,197,000,000 -1,196,000,000 -1,145,000,000 -1,154,000,000 -1,150,000,000 -1,185,000,000 -1,099,000,000 -1,090,000,000 -1,099,000,000 -1,108,000,000 -1,021,000,000 -1,016,000,000 -1,021,000,000 -1,017,000,000 -668,000,000 -671,000,000 -671,000,000 -669,000,000 -653,000,000 -653,000,000 -654,000,000 -653,000,000 -639,000,000 -640,000,000 -643,000,000 -655,000,000 -635,000,000 -636,000,000 -635,000,000 -641,000,000 -618,000,000 -617,000,000 -619,000,000 -623,000,000 -598,000,000 -597,000,000 -598,000,000 -605,000,000 -577,000,000 -577,000,000               
          stock option proceeds and other
        -98,000,000 -33,000,000 -3,000,000 11,000,000 -103,000,000 -19,000,000 16,000,000 -6,000,000 -97,000,000 25,000,000 41,000,000 53,000,000 -92,000,000                                                     
          net cash from financing activities
        -1,560,000,000 -6,029,000,000 -1,490,000,000 -1,836,000,000 -993,000,000 -1,642,000,000 -3,852,000,000 -4,023,000,000 14,644,000,000 967,000,000 -5,160,000,000 -2,173,000,000 -3,050,000,000 -3,246,000,000 -4,543,000,000 -3,520,000,000 -5,653,000,000 -3,967,000,000 -1,780,000,000 -3,182,000,000 -7,295,000,000 3,483,000,000 -2,587,000,000 -993,000,000 -1,054,000,000 -7,677,000,000 -941,000,000 18,268,000,000 -2,029,000,000 -578,000,000 -720,000,000 -1,015,000,000 -1,222,000,000 -1,352,000,000 -706,000,000 -1,006,000,000 -1,013,000,000 -590,000,000 -539,000,000 -524,000,000 -792,000,000 -1,086,000,000 -700,000,000 -883,000,000 -682,000,000 -231,000,000 -528,000,000 -486,000,000 -1,192,000,000 711,000,000 -620,000,000 -1,115,000,000 -44,000,000 -958,000,000 -1,689,000,000 -850,000,000 -836,000,000 -754,000,000 -704,000,000 -507,000,000 -692,000,000 -1,664,000,000 -698,000,000 -495,000,000 -486,000,000 
          effect of exchange rates on cash, cash equivalents and restricted cash
        -48,000,000 5,000,000 -4,000,000 128,000,000 66,000,000 -147,000,000 77,000,000 -22,000,000 -45,000,000 78,000,000 -38,000,000 -8,000,000 13,000,000 95,000,000 -66,000,000 -71,000,000 9,000,000 -54,000,000 -28,000,000 18,000,000 -38,000,000 87,000,000 31,000,000 60,000,000 -67,000,000                                         
          increase in cash, cash equivalents and restricted cash
        -635,000,000 -5,508,000,000 3,115,000,000 1,736,000,000 528,000,000             437,000,000 2,482,000,000 76,000,000 -3,652,000,000 -4,887,000,000 -502,000,000 4,116,000,000 3,426,000,000                                         
          cash, cash equivalents and restricted cash at beginning of period
        10,218,000,000 10,347,000,000 11,519,000,000  9,325,000,000  14,316,000,000  14,973,000,000  12,820,000,000                                         
          cash, cash equivalents and restricted cash at end of period
        9,583,000,000 -5,508,000,000 3,115,000,000 1,736,000,000 10,875,000,000 2,454,000,000 1,597,000,000 -3,038,000,000 9,334,000,000  -857,000,000 -623,000,000 9,048,000,000  -3,003,000,000 -1,619,000,000 12,579,000,000  2,482,000,000 76,000,000 11,321,000,000  -502,000,000 4,116,000,000 16,246,000,000                                         
          contingent consideration fair value adjustments
         15,000,000           -10,000,000 1,000,000 -32,000,000 -510,000,000 -1,160,000,000 -988,000,000 -165,000,000 556,000,000                                         
          proceeds from issuance of short-term debt obligations
                                                                       
          repayments of short-term debt obligations
             -269,000,000                                                           
          proceeds from issuance of long-term debt
                                                       1,477,000,000 12,000,000            
          repurchase of common stock
                 -4,000,000,000 -905,000,000 -250,000,000 -2,416,000,000 -585,000,000 -5,000,000,000 -2,751,000,000 -525,000,000 -1,236,000,000 -1,775,000,000 -1,465,000,000 -81,000,000 -7,000,000,000    -153,000,000 -167,000,000 -249,000,000 -220,000,000 -2,000,000,000 -231,000,000                         
          decrease in cash, cash equivalents and restricted cash
              1,597,000,000 -3,038,000,000 -2,185,000,000  -857,000,000 -623,000,000 -277,000,000  -3,003,000,000 -1,619,000,000 -1,737,000,000                                                 
          short-term debt obligations
                3,070,000,000 -353,000,000 -10,000,000 115,000,000 128,000,000 136,000,000 -72,000,000 88,000,000 42,000,000 -114,000,000 139,000,000 -123,000,000 -62,000,000 -3,000,000 -242,000,000 -48,000,000 26,000,000 16,000,000 31,000,000 157,000,000 -73,000,000 74,000,000 -71,000,000 -202,000,000 -344,000,000 -471,000,000 898,000,000                               
          issuance of long-term debt
                12,883,000,000     5,926,000,000         7,988,000,000       1,488,000,000                           
          repayment of long-term debt
                 -2,000,000,000 -239,000,000 -1,640,000,000 -2,785,000,000 -2,877,000,000 -5,769,000,000 -500,000,000 -1,000,000,000 -4,522,000,000 -1,250,000,000    -8,000,000,000 -6,000,000 -1,250,000,000   -750,000,000                               
          proceeds from sales of equity investment securities
                   5,000,000 62,000,000 5,000,000 63,000,000 148,000,000 2,000,000 1,521,000,000 244,000,000                                               
          cash, cash equivalents and restricted cash at beginning of year
                                                                         
          cash, cash equivalents and restricted cash at end of year
                                                                         
          equity investment losses/
                                                                         
          pension settlements and amortization
                        7,000,000 5,000,000 5,000,000 14,000,000 11,000,000 9,000,000 12,000,000 11,000,000 11,000,000 5,000,000 1,557,000,000 60,000,000 66,000,000 41,000,000 41,000,000 54,000,000 50,000,000 88,000,000 41,000,000 55,000,000 52,000,000 47,000,000 39,000,000 44,000,000 39,000,000 67,000,000 68,000,000 60,000,000 50,000,000                     
          iprd charge - myokardia acquisition
                                                                         
          asset acquisition charges
                         86,000,000 270,000,000 796,000,000 5,000,000 821,000,000 178,000,000     25,000,000 60,000,000 250,000,000 310,000,000   35,000,000 139,000,000 100,000,000                         
          equity investment gains
                         469,000,000 -465,000,000          -175,000,000                                     
          deferred income
                                 -1,000,000 4,000,000 -6,000,000 15,000,000 -8,000,000 69,000,000 23,000,000 -551,000,000 -89,000,000 -76,000,000 74,000,000 -509,000,000 182,000,000 28,000,000 235,000,000 65,000,000 325,000,000 -506,000,000 334,000,000 209,000,000 -19,000,000 96,000,000 327,000,000 263,000,000 83,000,000 404,000,000 215,000,000   43,000,000 -91,000,000 4,000,000 -21,000,000 -41,000,000 -57,000,000 116,000,000 -8,000,000 -26,000,000 35,000,000 
          sale and maturities of marketable securities
                                  176,000,000 938,000,000 1,350,000,000 926,000,000 373,000,000 638,000,000 442,000,000 2,116,000,000 2,013,000,000 1,120,000,000 1,163,000,000 1,135,000,000 880,000,000 1,034,000,000 1,760,000,000 345,000,000 641,000,000        242,000,000    1,047,000,000 1,147,000,000 2,190,000,000         
          purchase of marketable securities
                                  -1,205,000,000 -195,000,000 -242,000,000 -1,243,000,000 -615,000,000 -162,000,000 -285,000,000 -1,003,000,000 -1,393,000,000 -1,837,000,000 -1,204,000,000 -841,000,000 -1,053,000,000 -672,000,000 -523,000,000                         
          acquisition and other payments
                                  -9,000,000 -34,000,000 -15,000,000 -31,000,000 -45,000,000 -834,000,000 -336,000,000 -36,000,000 -353,000,000 -207,000,000 -112,000,000 -48,000,000 -44,000,000 -259,000,000 -8,000,000                         
          effect of exchange rates on cash and cash equivalents
                                  -21,000,000 3,000,000 3,000,000 -12,000,000 -3,000,000 -37,000,000 11,000,000 -7,000,000 25,000,000 6,000,000 28,000,000 -49,000,000 8,000,000 -3,000,000 11,000,000 -131,000,000 14,000,000 -3,000,000 25,000,000 28,000,000   2,000,000 9,000,000 -8,000,000 14,000,000 10,000,000 -2,000,000 10,000,000 -16,000,000 7,000,000 -4,000,000 -25,000,000 6,000,000 20,000,000 30,000,000 -9,000,000 -7,000,000 
          net increase in cash and cash equivalents
                                  2,085,000,000 21,069,000,000 424,000,000                                     
          cash and cash equivalents at beginning of period
                                  6,911,000,000  5,421,000,000  4,237,000,000  2,385,000,000  5,571,000,000  3,586,000,000  1,656,000,000  5,776,000,000  5,033,000,000  7,683,000,000 
          cash and cash equivalents at end of period
                                  2,085,000,000 21,069,000,000 7,335,000,000  409,000,000 -343,000,000 5,342,000,000  1,174,000,000 -440,000,000 3,910,000,000  498,000,000 290,000,000 2,644,000,000  -224,000,000 -2,095,000,000 6,294,000,000  569,000,000 -943,000,000 5,225,000,000  -50,000,000 466,000,000 1,355,000,000  -1,298,000,000 494,000,000 2,307,000,000  806,000,000 260,000,000 3,405,000,000  1,663,000,000 783,000,000 5,135,000,000 
          loss on equity investments
                                     268,000,000 -97,000,000                                   
          increase in cash and cash equivalents
                                         777,000,000 1,174,000,000 -440,000,000 -327,000,000 805,000,000 498,000,000 290,000,000 259,000,000 -1,590,000,000 -224,000,000 -2,095,000,000 723,000,000 720,000,000 569,000,000 -943,000,000 1,639,000,000       494,000,000 -3,469,000,000 1,305,000,000 806,000,000 260,000,000 -1,628,000,000     
          cash and cash equivalents at beginning of year
                                                                         
          cash and cash equivalents at end of year
                                                                         
          decrease in cash and cash equivalents
                                       -343,000,000 -79,000,000                    -301,000,000          1,663,000,000 783,000,000 -2,548,000,000 
          short-term borrowings
                                            192,000,000 23,000,000 85,000,000 50,000,000 -33,000,000 -503,000,000 -113,000,000 427,000,000 -260,000,000                     
          interest rate swap contract terminations
                                             42,000,000 -29,000,000 27,000,000 109,000,000 -4,000,000                 
          issuance of common stock
                                             37,000,000 12,000,000 61,000,000 71,000,000          40,000,000 173,000,000 270,000,000             
          net earnings attributable to noncontrolling interest
                                                 -9,000,000 -24,000,000   -14,000,000    -9,000,000 6,000,000 -14,000,000 1,000,000 2,000,000 -163,000,000 -381,000,000 -379,000,000 -386,000,000 -405,000,000 -381,000,000 -359,000,000 -353,000,000 -341,000,000 -358,000,000 
          other changes
                                                  305,000,000                       
          purchases of marketable securities
                                                  -811,000,000 -651,000,000 -821,000,000 -908,000,000 -1,803,000,000 -1,928,000,000 -1,080,000,000 -411,000,000 -598,000,000 -572,000,000 -278,000,000 -106,000,000 -75,000,000 -811,000,000 -2,615,000,000 -1,475,000,000 -1,157,000,000 -1,953,000,000 -2,234,000,000 -2,120,000,000 -116,000,000 -707,000,000 -2,880,000,000 
          additions to property, plant and equipment and capitalized software
                                                  -234,000,000 -165,000,000 -136,000,000 -191,000,000 -107,000,000 -110,000,000 -118,000,000 -200,000,000 -124,000,000 -98,000,000 -115,000,000 -175,000,000 -137,000,000 -113,000,000 -123,000,000 -134,000,000 -84,000,000 -74,000,000 -75,000,000 -125,000,000 -89,000,000 -81,000,000 -129,000,000 
          divestitures and other proceeds
                                                  379,000,000                       
          acquisitions and other payments
                                                  -37,000,000                       
          issuances of common stock
                                                  30,000,000 27,000,000 174,000,000 59,000,000 29,000,000 28,000,000 172,000,000         236,000,000 130,000,000       
          net (earnings)/loss attributable to noncontrolling interest
                                                    -13,000,000    1,000,000                 
          gain on sale of businesses and other
                                                    -234,000,000 -7,000,000                    
          proceeds from sale and maturities of marketable securities
                                                    1,508,000,000 1,324,000,000 1,833,000,000 562,000,000 376,000,000    551,000,000       1,687,000,000 758,000,000 585,000,000 1,131,000,000   
          business divestitures and other proceeds
                                                    203,000,000                     
          business acquisitions and other payments
                                                                         
          proceeds from amylin diabetes alliance
                                                                         
          short-term debt borrowings
                                                     199,000,000 40,000,000 84,000,000 -79,000,000                 
          repurchases of common stock
                                                                         
          proceeds from sale of businesses
                                                                         
          other investing activities
                                                      123,000,000 -139,000,000 -21,000,000                 
          proceeds from sale of business
                                                       104,000,000 3,055,000,000                 
          proceeds from sale of businesses and other investing activities
                                                            3,000,000     2,000,000 25,000,000 8,000,000 114,000,000     
          purchase of businesses, net of cash acquired
                                                             -5,039,000,000 -2,491,000,000         
          short-term debt borrowings/
                                                            551,000,000          -49,000,000   
          increase/(decrease) in cash and cash equivalents
                                                         1,815,000,000 -50,000,000               
          proceeds from amylin diabetes collaboration
                                                                         
          sale of businesses and other investing activities
                                                          5,000,000    1,000,000 3,000,000 12,000,000         
          purchases of businesses, net of cash acquired
                                                                         
          long-term debt repayments
                                                             -1,999,000,000 -109,000,000 -24,000,000 -54,000,000     
          interest rate swap terminations
                                                             2,000,000 207,000,000 85,000,000 4,000,000     
          common stock repurchases
                                                          -53,000,000 -83,000,000 -297,000,000 -492,000,000 -1,051,000,000 -521,000,000 -339,000,000 -362,000,000 -474,000,000 -237,000,000 -148,000,000 -223,000,000 -188,000,000   
          net cash provided by/(used in) investing activities
                                                                         
          net change in short-term borrowings
                                                                         
          u.s. and foreign income taxes payable
                                                            77,000,000 -132,000,000 7,000,000 97,000,000 -22,000,000 -114,000,000 97,000,000 -47,000,000 -70,000,000 -49,000,000 8,000,000 -89,000,000 -106,000,000 
          dividends paid
                                                            -580,000,000 -561,000,000 -571,000,000 -575,000,000 -579,000,000 -560,000,000 -564,000,000 -565,000,000 -565,000,000 -549,000,000 -550,000,000 -552,000,000 -551,000,000 
          other deferred income
                                                             195,000,000            
          deferred income from diabetes collaboration
                                                                         
          short-term borrowings/
                                                              -101,000,000 91,000,000 30,000,000  -3,000,000 52,000,000 18,000,000     
          stock option exercises
                                                              83,000,000 155,000,000 159,000,000         
          depreciation
                                                               90,000,000 85,000,000 115,000,000 105,000,000 111,000,000 117,000,000 125,000,000 102,000,000 124,000,000 122,000,000 
          amortization
                                                               102,000,000 101,000,000 92,000,000 93,000,000 95,000,000 73,000,000 73,000,000 66,000,000 67,000,000 65,000,000 
          deferred income tax expense
                                                               -124,000,000 204,000,000 142,000,000 30,000,000 66,000,000 177,000,000     
          stock-based compensation expense
                                                               40,000,000 42,000,000 41,000,000 39,000,000 43,000,000 38,000,000     
          gain related to divestitures of discontinued operations
                                                                         
          mead johnson’s cash at split-off
                                                                         
          short-term debt repayments
                                                                         
          long-term debt borrowings
                                                                       
          proceeds from mead johnson initial public offering
                                                                         
          proceeds from sales and maturities of marketable securities
                                                                         
          purchase of amira pharmaceuticals, inc., net of cash acquired
                                                                         
          issuances of common stock and excess tax benefits from share-based arrangements
                                                                    53,000,000 41,000,000 89,000,000 40,000,000 82,000,000 
          acquired in-process research and development
                                                                         
          gain on sale of imclone shares
                                                                         
          other gains
                                                                     2,000,000 -19,000,000 -5,000,000 -10,000,000 
          proceeds from sale of businesses, property, plant and equipment and other investments
                                                                     10,000,000 22,000,000 -2,000,000 37,000,000 
          proceeds from divestitures of discontinued operations
                                                                         
          proceeds from sale of imclone shares
                                                                         
          proceeds from sale and leaseback of properties
                                                                         
          impairment of manufacturing operations
                                                                      7,000,000   
          changes in other operating assets and liabilities
                                                                      322,000,000 -182,000,000 -557,000,000 
          purchase of medarex, inc., net of cash acquired
                                                                         
          interest rate swap termination
                                                                        
          impairment charge
                                                                        200,000,000 
          proceeds from sale of marketable securities
                                                                        453,000,000 
          short-term debt (repayments)/borrowings
                                                                        -17,000,000